Announcement

Collapse
No announcement yet.

Canada FluWatch Weekly Reports 2013-2014 Season Weeks 33 and 34

Collapse
This is a sticky topic.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 46

    FluWatch report: November 10 to 16, 2013 (Week 46)

    Posted 2013-11-22For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 316 KB - 10 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w46_13/pdf/fw2013-46-eng.pdf">FluWatch report: November 10 to 16, 2013 (Week 46) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 316 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada continued to increase for the fourth week in a row, indicating that the 2013-14 season has started.
    • Laboratory detections of influenza continued to increase, primarily influenza A.
    • Two influenza outbreaks in long-term care facilities were reported in week 46, and four regions reported localized influenza/ILI activity.
    • Both paediatric and adult hospitalizations with influenza continued to be reported in week 46.
    • The ILI consultation rate has been stable over the past four weeks.
    Influenza/ILI Activity (geographic spread)

    In week 46, three regions in ON(2) and QC(1) reported localized activity and 13 regions (in BC(1), AB(2), SK(1), ON(4), QC(4) and NB(1)) reported sporadic activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 46





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests continued to increase, from 42 in week 45 to 63 in week 46, bringing the percentage of positive influenza tests to 2.6%, driven predominantly by detections of influenza A (Figure 2). Cumulative influenza virus detections by type/subtype to date have been predominantly influenza A (81%) with more A(H1N1)pdm09 identified compared to A(H3) among those subtyped (Table 1). Detailed information on age and type/subtype has been received for 156 cases to date this season. Adults 45-64 years of age represent 36% of cases to date (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    In week 46, the number of positive tests for parainfluenza and RSV continued their slow increase. Despite an increasing number of tests performed, positive tests for rhinovirus have declined over the past five weeks. Rhinovirus and parainfluenza remained the two predominant viruses detected in week 46 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (November 10 to November 16, 2013)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to November 16, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=lightred headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=lightred headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=lightred headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=lightred headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=lightred headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=lightred headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">3 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">2 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">1 </TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">1 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">10 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">3 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">5 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">2 </TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">4 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">18 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">17 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">48 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">40 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">8 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">12 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">3 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">3 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">8 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">5 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">3 </TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">0 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">1 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">1 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">4 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">4 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">1 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">20 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">13 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">4 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">3 </TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">1 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">60 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">27 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">23 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">10 </TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">8 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">5 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">5 </TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">10 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">21 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">0 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">21 </TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">12 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">1 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">1 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">2 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">1 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">0 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">1 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">1 </TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">0 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">51 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac4">34 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac5">8 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac1 ac2 ac6">9 </TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">12 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">154 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac11">80 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac12">37 </TD><TD class="alignRight lightred" headers="ar1 ar12 ac8 ac9 ac13">37 </TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">37 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">81.0% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac4">66.7% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac5">15.7% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac1 ac2 ac6">17.6% </TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">19.0% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">80.6% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac11">51.9% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac12">24.0% </TD><TD class="alignRight lightred" headers="ar1 ar13 ac8 ac9 ac13">24.0% </TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">19.4% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (November 10 to November 16, 2013)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to November 16, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="lightred " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="lightred " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="lightred " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="lightred " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="lightred " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="lightred " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">5 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">3 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">2 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">3 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">20 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">11 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">3 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">6 </TD><TD class=alignRight headers="br1 br2 bc8 bc14">8 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">28 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">17.9% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">7 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">7 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">1 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">14 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">10 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">1 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">3 </TD><TD class=alignRight headers="br1 br3 bc8 bc14">4 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">18 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">11.5% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">7 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">5 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">2 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">27 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">16 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">4 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">7 </TD><TD class=alignRight headers="br1 br4 bc8 bc14">3 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">30 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">19.2% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">10 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">7 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">2 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">1 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">2 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">47 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">25 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">14 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">8 </TD><TD class=alignRight headers="br1 br5 bc8 bc14">9 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">56 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">35.9% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">5 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">1 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">4 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">2 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">16 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">5 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">4 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">7 </TD><TD class=alignRight headers="br1 br6 bc8 bc14">8 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">24 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">15.4% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.0% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">34 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc4">23 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc5">2 </TD><TD class="alignRight lightred" headers="br1 br8 bc1 bc2 bc6">9 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">8 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">124 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc11">67 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc12">26 </TD><TD class="alignRight lightred" headers="br1 br8 bc8 bc9 bc13">31 </TD><TD class=alignRight headers="br1 br8 bc8 bc14">32 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">156 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">81.0% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc4">67.6% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc5">5.9% </TD><TD class="alignRight lightred" headers="br1 br9 bc1 bc2 bc6">26.5% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">19.0% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">79.5% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc11">54.0% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc12">21.0% </TD><TD class="alignRight lightred" headers="br1 br9 bc8 bc9 bc13">25.0% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">20.5% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 20 influenza viruses [four A(H3N2), five A(H1N1)pdm09 and 11 influenza B]. Sixteen of the 20 viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine; four influenza B viruses were similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 20

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b (e.g. A/Texas/50/2012), and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 19 influenza viruses for resistance to oseltamivir and zanamivir, and all were sensitive. Eight influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">4</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">4</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">4</TD><TD class=alignCenter headers="cr2 cc9">4(100%)</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">5</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">5</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">4</TD><TD class=alignCenter headers="cr3 cc9">4(100%)</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">10</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">10</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">19</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">19</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">8</TD><TD class=alignCenter headers="cr5 cc9">8(100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased slightly from 19.9/1,000 in week 45 to 16.9/1,000 in week 46, but was similar to the previous three weeks (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    Two new influenza outbreaks in long-term care facilities were reported in week 46 (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance for sales of influenza antivirals has not yet begun for the 2013-14 influenza season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 46, two new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network: one child 2-4 years of age and one 10-16 years of age, both with influenza A(H1N1)pdm09 (Figure 8a).
    To date this season, a total of 10 influenza-associated paediatric hospitalizations have been reported by the IMPACT network (Table 4). One ICU admission was required in a child 2-4 years of age with influenza B. No deaths have been reported (Figure 9a).

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network began on November 15th 2013. Two new hospitalizations were reported in week 46, both adults 20-44 years of age with influenza A. No ICU admissions or deaths were reported in week 46 (Figure 8b).
    To date this season, 11 influenza-associated hospitalizations have been reported by the PCIRN-SOS network, all with influenza A. The majority (64%) have been adults over 45 years of age (Table 5). ICU admission was required for one hospitalization and no deaths have been reported (Figure 9b).

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 16, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class=lightred headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class=lightred headers="dc1 dc2">A(H3) </TH><TH id=dc6 class=lightred headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">1 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">1 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">0 </TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">1 (10%) </TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">0 </TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">0 </TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">3 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">2 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">1 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">3 </TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">6 (60%) </TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">1 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">1 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">0 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">1 </TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">2 (20%) </TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">1 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">1 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">0 </TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">1 (10%) </TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">6 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc4">4 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc5">0 </TD><TD class="lightred alignRight" headers="dr1 dr7 dc1 dc2 dc6">2 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">4 </TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">10 </TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">60.0% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc4">66.7% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc5">0.0% </TD><TD class="lightred alignRight" headers="dr1 dr8 dc1 dc2 dc6">33.3% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">40.0% </TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0% </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to November 16, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class=lightred headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class=lightred headers="ec1 ec2">A(H3) </TH><TH id=ec6 class=lightred headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">0</TD><TD class=alignRight headers="er1 er2 ec1 ec7">0</TD><TD class=alignRight headers="er1 er2 ec1 ec8">0</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">4</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">1</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">3</TD><TD class=alignRight headers="er1 er3 ec1 ec7">0</TD><TD class=alignRight headers="er1 er3 ec1 ec8">4 (36%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">4</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">1</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">3</TD><TD class=alignRight headers="er1 er4 ec1 ec7">0</TD><TD class=alignRight headers="er1 er4 ec1 ec8">4 (36%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">3</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">3</TD><TD class=alignRight headers="er1 er5 ec1 ec7">0</TD><TD class=alignRight headers="er1 er5 ec1 ec8">3 (27%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">11</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec4">1</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec5">1</TD><TD class="alignRight lightred" headers="er1 er6 ec1 ec2 ec6">9</TD><TD class=alignRight headers="er1 er6 ec1 ec7">0</TD><TD class=alignRight headers="er1 er6 ec1 ec8">11</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">100%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec4">9%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec5">9%</TD><TD class="alignRight lightred" headers="er1 er7 ec1 ec2 ec6">82%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">0%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 46, seven new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The cases were as follows: one child 2-4 years, two adults 20-44 years, two adults 45-64 years and two adults ≥65 years of age. All cases had influenza A, four A(H1N1)pdm09 and three A(unsubtyped). One ICU admission was reported in a child 2-4 years of age with A(H1N1)pdm09. No deaths were reported.
    To date this season, 36 influenza-associated hospitalizations have been reported, of which 30 (83%) had influenza A (Table 6). A greater proportion of cases under 20 years of age had influenza B (50%) compared to those 20 years of age or older (3.8%). Four ICU admissions have been reported this season, three in adults 45-64 years of age and one in a child 2-4 years of age, all with A(H1N1)pdm09. No deaths have been reported. It is important to note that the hospitalization or death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Data from the Aggregate Surveillance System may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 16, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=lightred headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=lightred headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=lightred headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">3</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">1</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">1</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">1</TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">4</TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">7 (19%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">1 (3%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">2</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">1</TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">2 (6%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">4</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">1</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">3</TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">4 (11%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">14</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">5</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">6</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">3</TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">15 (42%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">7</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">4</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">1</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">2</TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">7 (19%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">30</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc4">12</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc5">8</TD><TD class="alignRight lightred" headers="fr1 fr8 fc1 fc2 fc6">10</TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">6</TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">36</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">83.3%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc4">40.0%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc5">26.7%</TD><TD class="alignRight lightred" headers="fr1 fr9 fc1 fc2 fc6">33.3%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">16.7%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 45

    FluWatch report: November 3 to 9, 2013 (Week 45)

    Posted 2013-11-15For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w45_13/pdf/fw2013-45-eng.pdf">FluWatch report: November 3 to 9, 2013 (Week 45) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents



    Overall Summary
    • Influenza activity in Canada continued to increase in week 45.
    • Laboratory detections of influenza continued to increase, primarily influenza A.
    • One influenza outbreak in a long-term care facility was reported in week 45, resulting in one region reporting localized influenza/ILI activity. An increasing number of regions reported sporadic activity.
    • Both paediatric and adult hospitalizations with influenza continued to be reported in week 45.
    • The ILI consultation rate has been stable over the past three weeks.
    Influenza/ILI Activity (geographic spread)

    In week 45, one region in Quebec reported localized activity and 16 regions (in BC(2), AB(3), SK(2), MB(2), ON(4), QC(2) and NL(1)) reported sporadic activity (Figure 1).
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 45





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests increased for the third week in a row, from 27 in week 44 to 41 in week 45, bringing the percentage of positive influenza tests to 1.6%, driven predominantly by detections of influenza A (Figure 2). Cumulative influenza virus detections by type/subtype to date have been predominantly influenza A (80%) with more A(H1N1)pdm09 identified compared to A(H3) among those subtyped (Table 1). Detailed information on age and type/subtype has been received for 100 cases to date this season. Adults 45-64 years of age represent 37% of cases to date (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The numbers of positive tests for parainfluenza, adenovirus and RSV have been increasing slowly in recent weeks. Rhinovirus and parainfluenza remained the two predominant viruses detected in week 45 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14

    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (November 3 to November 9, 2013)

    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to November 9, 2013)

    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=bg-colour-blue headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=bg-colour-blue headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=bg-colour-blue headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=bg-colour-blue headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=bg-colour-blue headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=bg-colour-blue headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">4 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">1 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">3 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac10">7 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac11">3 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac12">3 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac13">1 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac14">3 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">10 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">7 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">2 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac7">3 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac10">29 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac11">20 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac12">7 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac13">2 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac14">12 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">2 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac10">5 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac11">2 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac13">3 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac14">0 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">2 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">2 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac10">3 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac11">3 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac14">1 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">12 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">5 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">5 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">2 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac7">1 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac10">38 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac11">12 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac12">18 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac13">8 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac14">7 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">5 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">5 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac7">1 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac10">16 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac13">16 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac14">2 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">0</TD><TD class=alignCenter headers="ar1 ar8 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac10">1 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac11">1 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac14">0 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac10">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac10">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac10">1</TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac13">1 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac14">0 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">36 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac1 ac2 ac4">16 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac1 ac2 ac5">9 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac1 ac2 ac6">11 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac7">5 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac9 ac10">100 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac8 ac9 ac11">41 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac8 ac9 ac12">28 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac8 ac9 ac13">31 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac14">25 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="ar1 ar13 ac1 ac2 ac3">87.8% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac1 ac2 ac4">44.4% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac1 ac2 ac5">25.0% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac1 ac2 ac6">30.6% </TD><TD class=alignCenter headers="ar1 ar13 ac1 ac7">12.2% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac9 ac10">80.0% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac8 ac9 ac11">41.0% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac8 ac9 ac12">28.0% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac8 ac9 ac13">31.0% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac14">20.0% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (November 3 to November 9, 2013)

    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to November 9, 2013)

    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="bg-colour-blue " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="bg-colour-blue " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="bg-colour-blue " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="bg-colour-blue " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="bg-colour-blue " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="bg-colour-blue " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">2 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">2 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">14 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">7 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">3 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">4 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">5 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc16">19 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc17">19.0% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">4 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">1 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">1 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">2 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">8 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">1 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">6 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">2 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc16">10 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc17">10.0% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">7 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">4 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">3 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">18 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">7 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">3 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">8 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">3 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc16">21 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc17">21.0% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">4 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">1 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">1 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">2 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">32 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">14 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">11 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">7 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">5 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc16">37 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc17">37.0% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">9 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">2 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">4 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">3 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">4 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc16">13 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc17">13.0% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc16">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc17">0.0% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">17 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc1 bc2 bc4">6 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc1 bc2 bc5">2 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc1 bc2 bc6">9 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">3 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">81 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc8 bc9 bc11">31 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc8 bc9 bc12">22 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc8 bc9 bc13">28 </TD><TD class=alignCenter headers="br1 br8 bc8 bc14">19 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc16">100 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="br1 br9 bc1 bc2 bc3">85.0% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc1 bc2 bc4">35.3% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc1 bc2 bc5">11.8% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc1 bc2 bc6">52.9% </TD><TD class=alignCenter headers="br1 br9 bc1 bc7">15.0% </TD><TD class=alignCenter headers="br1 br9 bc8 bc9 bc10">81.0% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc8 bc9 bc11">38.3% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc8 bc9 bc12">27.2% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc8 bc9 bc13">34.6% </TD><TD class=alignCenter headers="br1 br9 bc8 bc14">19.0% </TD><TD class=alignCenter></TD><TD class=alignCenter></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized 11 influenza viruses [four A(H3N2), two A(H1N1)pdm09 and five influenza B]. Ten of the eleven viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine; one influenza B virus was similar to the strain recommended by the WHO for the 2011-12 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 11

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested 11 influenza viruses for resistance to oseltamivir and zanamivir, and all were sensitive. Six influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">4</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">4</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">4</TD><TD class=alignCenter headers="cr2 cc9">4(100%)</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">2</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">2</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">2</TD><TD class=alignCenter headers="cr3 cc9">2(100%)</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">5</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">5</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">11</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">11</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">6</TD><TD class=alignCenter headers="cr5 cc9">6(100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased slightly from 17.2/1,000 in week 44 to 18.6/1,000 in week 45, but was similar to the previous two weeks (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    One new influenza outbreak in a long-term care facility was reported in week 45 (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance for sales of influenza antivirals has not yet begun for the 2013-14 influenza season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 45, two new laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network: two children 5-9 years of age, one with influenza A(H1N1)pdm09 and one with influenza B (Figure 8a).
    To date this season, a total of seven influenza-associated paediatric hospitalizations have been reported by the IMPACT network (Table 4). One ICU admission was required in a child 2-4 years of age with influenza B. No deaths have been reported (Figure 9a).

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network will begin on November 15th 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance. Two new hospitalizations were reported in week 45, one adult 20-44 years of age and one 45-64 years of age, both with influenza A. No ICU admissions or deaths were reported in week 45 (Figure 8b).
    To date this season, eight influenza-associated hospitalizations have been reported by the PCIRN-SOS network, all with influenza A. The majority have been adults over 45 years of age (Table 5). ICU admission was required for one hospitalization and no deaths have been reported (Figure 9b).

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 9, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="bg-colour-blue " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="bg-colour-blue " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="bg-colour-blue " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    </TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc3">1</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc6">1</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc7">0</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc8">1 (14%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc3">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc6">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc7">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc8">0</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc3">2</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc4">1</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc6">1</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc7">2</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc8">4 (57%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc3">1</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc4">1</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc6">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc7">1</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc8">2(29%)</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc3">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc6">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc7">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc8">0</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignCenter headers="dr1 dr7 dc1 dc2 dc3">4</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr7 dc1 dc2 dc4">2</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr7 dc1 dc2 dc5">0</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr7 dc1 dc2 dc6">2</TD><TD class=alignCenter headers="dr1 dr7 dc1 dc7">3</TD><TD class=alignCenter headers="dr1 dr7 dc1 dc8">7</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignCenter headers="dr1 dr8 dc1 dc2 dc3">57.1%</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr8 dc1 dc2 dc4">50.0%</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr8 dc1 dc2 dc5">0.0%</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr8 dc1 dc2 dc6">50.0%</TD><TD class=alignCenter headers="dr1 dr8 dc1 dc7">42.9%</TD><TD class=alignCenter headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14

    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to November 9, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="bg-colour-blue " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="bg-colour-blue " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="bg-colour-blue " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    </TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignCenter headers="er1 er2 ec1 ec2 ec3">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec6">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec8">0</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignCenter headers="er1 er3 ec1 ec2 ec3">1</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec6">1</TD><TD class=alignCenter headers="er1 er3 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec8">1(13%)</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignCenter headers="er1 er4 ec1 ec2 ec3">4</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec5">1</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec6">3</TD><TD class=alignCenter headers="er1 er4 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er4 ec1 ec8">4 (50%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignCenter headers="er1 er5 ec1 ec2 ec3">3</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec6">3</TD><TD class=alignCenter headers="er1 er5 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er5 ec1 ec8">3 (38%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignCenter headers="er1 er6 ec1 ec2 ec3">8</TD><TD class="bg-colour-blue alignCenter" headers="er1 er6 ec1 ec2 ec4">0</TD><TD class="bg-colour-blue alignCenter" headers="er1 er6 ec1 ec2 ec5">1</TD><TD class="bg-colour-blue alignCenter" headers="er1 er6 ec1 ec2 ec6">7</TD><TD class=alignCenter headers="er1 er6 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er6 ec1 ec8">8</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignCenter headers="er1 er7 ec1 ec2 ec3">100%</TD><TD class="bg-colour-blue alignCenter" headers="er1 er7 ec1 ec2 ec4">0%</TD><TD class="bg-colour-blue alignCenter" headers="er1 er7 ec1 ec2 ec5">13%</TD><TD class="bg-colour-blue alignCenter" headers="er1 er7 ec1 ec2 ec6">88%</TD><TD class=alignCenter headers="er1 er7 ec1 ec7">0%</TD><TD class=alignCenter headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 45, five new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* One case was reported in each of the following age-groups: 15-19 years, 20-44 years, 45-64 years; and two cases were ≥65 years of age. Four cases had influenza A(unsubtyped) and one had A(H1N1)pdm09. No ICU admissions or deaths were reported in week 45.
    To date this season, 25 influenza-associated hospitalizations have been reported, of which 19 (76%) had influenza A (Table 6). Consistent with the data from IMPACT and PCIRN-SOS, there is a greater proportion of cases of influenza B among children under 5 years of age, whereas influenza A is predominant among adults over 45 years of age. Two ICU admissions have been reported in adults 45-64 years of age and no deaths have been reported. It is important to note that the cause of death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.

    * Note: Data from the Aggregate Surveillance System may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 9, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=bg-colour-blue headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=bg-colour-blue headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=bg-colour-blue headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    </TD></TR></TFOOT><TBODY><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc3">2</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc4">0</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc5">1</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc2 fc6">1</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc7">4</TD><TD class=alignCenter headers="fr1 fr2 fc1 fc8">6 (24%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc3">0</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc4">0</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc5">0</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc2 fc6">0</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc7">1</TD><TD class=alignCenter headers="fr1 fr3 fc1 fc8">1 (4%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc3">1</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc4">0</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc5">0</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc2 fc6">1</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc7">0</TD><TD class=alignCenter headers="fr1 fr4 fc1 fc8">1(4%)</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc3">1</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc4">0</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc5">0</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc2 fc6">1</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc7">0</TD><TD class=alignCenter headers="fr1 fr5 fc1 fc8">1(4%)</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc3">9</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc4">1</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc5">6</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc2 fc6">2</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc7">1</TD><TD class=alignCenter headers="fr1 fr6 fc1 fc8">10 (40%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc3">6</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc4">2</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc5">1</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc2 fc6">3</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc7">0</TD><TD class=alignCenter headers="fr1 fr7 fc1 fc8">6 (24%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignCenter headers="fr1 fr8 fc1 fc2 fc3">19</TD><TD class="alignCenter bg-colour-blue" headers="fr1 fr8 fc1 fc2 fc4">3</TD><TD class="alignCenter bg-colour-blue" headers="fr1 fr8 fc1 fc2 fc5">8</TD><TD class="alignCenter bg-colour-blue" headers="fr1 fr8 fc1 fc2 fc6">8</TD><TD class=alignCenter headers="fr1 fr8 fc1 fc7">6</TD><TD class=alignCenter headers="fr1 fr8 fc1 fc8">25</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignCenter headers="fr1 fr9 fc1 fc2 fc3">76.0%</TD><TD class="alignCenter bg-colour-blue" headers="fr1 fr9 fc1 fc2 fc4">15.8%</TD><TD class="alignCenter bg-colour-blue" headers="fr1 fr9 fc1 fc2 fc5">42.1%</TD><TD class="alignCenter bg-colour-blue" headers="fr1 fr9 fc1 fc2 fc6">42.1%</TD><TD class=alignCenter headers="fr1 fr9 fc1 fc7">24.0%</TD><TD class=alignCenter headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 44


    <!-- CONTENT TITLE BEGINS | DEBUT DU TITRE DU CONTENU -->FluWatch report: October 27 to November 2, 2013 (Week 44)

    Posted 2013-11-08For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w44_13/pdf/fw2013-44-eng.pdf">FluWatch report: October 27 to November 2, 2013 (Week 44) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents

    Overall Summary
    • Influenza activity in Canada increased slightly in week 44.
    • Laboratory detections of influenza increased and ten regions reported sporadic influenza activity.
    • Both paediatric and adult hospitalizations with influenza were reported in week 44.
    • The ILI consultation rate declined slightly in week 44.

    Influenza/ILI Activity (geographic spread)

    In week 44, ten regions (in BC(2), AB(2), SK(1), ON(3) and QC(2)) reported sporadic activity (Figure 1). The number of regions reporting sporadic activity has increased over the past three weeks.
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 44





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests increased for the second week in a row, from 21 in week 43 to 27 in week 44, bringing the percentage of positive influenza tests to 1.2%, driven predominantly by detections of influenza A (Figure 2). Cumulative influenza virus detections by type/subtype to date have been predominantly influenza A (76%) with more A(H1N1)pdm09 identified compared to A(H3) among those subtyped (Table 1). Detailed information on age and type/subtype has been received for 69 cases to date this season. The majority of cases have been adults 45-64 years of age (44%), followed by children under 5 years of age (23%) (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for parainfluenza and RSV increased in week 44, although rhinovirus and parainfluenza remained the two predominant viruses detected (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (October 27 to November 2, 2013)</TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to November 2, 2013)</TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=bg-colour-blue headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=bg-colour-blue headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=bg-colour-blue headers="ac1 ac2">A(UnS)</TH><TH class=alignCenter headers="ac1 ac7">B Total</TH><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=bg-colour-blue headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=bg-colour-blue headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=bg-colour-blue headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11><SUP>1 </SUP>Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    <SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections. </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">2 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">2 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac10">3 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac11">2 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac9 ac13">1 </TD><TD class=alignCenter headers="ar1 ar2 ac8 ac14">3 </TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">5 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">3 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">2 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac7">2 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac10">19 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac11">12 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac12">5 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac9 ac13">2 </TD><TD class=alignCenter headers="ar1 ar3 ac8 ac14">9 </TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac10">3 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac11">1 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac9 ac13">2 </TD><TD class=alignCenter headers="ar1 ar4 ac8 ac14">0 </TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">1 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac7">1 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac10">1 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac11">1 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar5 ac8 ac14">1 </TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">12 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">4 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">4 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">4 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac10">26 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac11">7 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac12">12 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac9 ac13">7 </TD><TD class=alignCenter headers="ar1 ar6 ac8 ac14">6 </TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">2 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">2 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac7">1 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac10">11 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac9 ac13">11 </TD><TD class=alignCenter headers="ar1 ar7 ac8 ac14">1 </TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac10">1 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac11">1 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar8 ac8 ac14">0 </TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac10">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar9 ac8 ac14">0 </TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac10">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar10 ac8 ac14">0 </TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac7">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac10">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac11">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac9 ac13">0 </TD><TD class=alignCenter headers="ar1 ar11 ac8 ac14">0 </TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">23 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac1 ac2 ac4">11 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac1 ac2 ac5">4 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac1 ac2 ac6">8 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac7">4 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac9 ac10">64 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac8 ac9 ac11">24 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac8 ac9 ac12">17 </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar12 ac8 ac9 ac13">23 </TD><TD class=alignCenter headers="ar1 ar12 ac8 ac14">20 </TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="ar1 ar13 ac1 ac2 ac3">85.2% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac1 ac2 ac4">47.8% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac1 ac2 ac5">17.4% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac1 ac2 ac6">34.8% </TD><TD class=alignCenter headers="ar1 ar13 ac1 ac7">14.8% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac9 ac10">76.2% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac8 ac9 ac11">37.5% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac8 ac9 ac12">26.6% </TD><TD class="bg-colour-blue alignCenter" headers="ar1 ar13 ac8 ac9 ac13">35.9% </TD><TD class=alignCenter headers="ar1 ar13 ac8 ac14">23.8% </TD></TR></TBODY></TABLE>

    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (October 27 to November 2, 2013)</TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to November 2, 2013)</TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class="bg-colour-blue " headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class="bg-colour-blue " headers="bc1 bc2">A(H3)</TH><TH id=bc6 class="bg-colour-blue " headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class="bg-colour-blue " headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class="bg-colour-blue " headers="bc8 bc9">A(H3)</TH><TH id=bc13 class="bg-colour-blue " headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13><SUP>2 </SUP>Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    <SUP>3 </SUP>Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available. </TD></TR></TFOOT><TBODY><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">3 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">2 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">12 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">5 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">3 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">4 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">4 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc16">16 </TD><TD class=alignCenter headers="br1 br2 bc8 bc15 bc17">23.2% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">2 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">2 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">1 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc16">3 </TD><TD class=alignCenter headers="br1 br3 bc8 bc15 bc17">4.3% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">2 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">2 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">8 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">2 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">5 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">2 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc16">10 </TD><TD class=alignCenter headers="br1 br4 bc8 bc15 bc17">14.5% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">3 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">3 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">25 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">9 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">8 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">8 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">5 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc16">30 </TD><TD class=alignCenter headers="br1 br5 bc8 bc15 bc17">43.5% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">7 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">3 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">3 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">3 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc16">10 </TD><TD class=alignCenter headers="br1 br6 bc8 bc15 bc17">14.5% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc16">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc15 bc17">0.0% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">9 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc1 bc2 bc4">1 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc1 bc2 bc5">0 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc1 bc2 bc6">8 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">54 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc8 bc9 bc11">17 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc8 bc9 bc12">15 </TD><TD class="bg-colour-blue alignCenter" headers="br1 br8 bc8 bc9 bc13">22 </TD><TD class=alignCenter headers="br1 br8 bc8 bc14">15 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc16">69 </TD><TD class=alignCenter headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignCenter headers="br1 br9 bc1 bc2 bc3">90.0% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc1 bc2 bc4">11.1% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc1 bc2 bc5">0.0% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc1 bc2 bc6">88.9% </TD><TD class=alignCenter headers="br1 br9 bc1 bc7">10.0% </TD><TD class=alignCenter headers="br1 br9 bc8 bc9 bc10">78.3% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc8 bc9 bc11">31.5% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc8 bc9 bc12">27.8% </TD><TD class="bg-colour-blue alignCenter" headers="br1 br9 bc8 bc9 bc13">40.7% </TD><TD class=alignCenter headers="br1 br9 bc8 bc14">21.7% </TD><TD class=alignCenter></TD><TD class=alignCenter></TD></TR></TBODY></TABLE>

    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized nine influenza viruses [two A(H3N2), two A(H1N1)pdm09 and five influenza B]. Eight of the nine viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine; one influenza B virus was similar to the strain recommended by the WHO for the 2012-13 vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N = 9

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3
    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested nine influenza viruses for resistance to oseltamivir and zanamivir, and all were sensitive. Four influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">2</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">2</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">2</TD><TD class=alignCenter headers="cr2 cc9">2(100%)</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">2</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">2</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">2</TD><TD class=alignCenter headers="cr3 cc9">2(100%)</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">5</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">5</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">9</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">9</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">4</TD><TD class=alignCenter headers="cr5 cc9">4(100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased slightly from 18.2/1,000 in week 43 to 16.7/1,000 in week 44 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    No new influenza outbreaks were reported in week 44 (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance for sales of influenza antivirals has not yet begun for the 2013-14 influenza season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 44, one laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalization was reported by the Immunization Monitoring Program Active (IMPACT) network: a child 2-4 years of age with influenza A(H1N1)pdm09 (Figure 8a).
    To date this season, a total of five influenza-associated paediatric hospitalizations have been reported by the IMPACT network: one child 0-5 months of age and four 2-4 years of age. One ICU admission was required in a child 2-4 years of age with influenza B. No deaths have been reported (Figure 9a and Table 4).
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network will begin on November 15th 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance. One new hospitalization was reported in week 44, an adult ≥65 years of age with influenza A. No ICU admissions or deaths were reported in week 44 (Figure 8b).
    To date this season, six influenza-associated hospitalizations have been reported by the PCIRN-SOS network, all adults over 45 years of age with influenza A. ICU admission was required for one hospitalization and no deaths have been reported (Figure 9b and Table 5).
    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 2, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class="bg-colour-blue " headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class="bg-colour-blue " headers="dc1 dc2">A(H3) </TH><TH id=dc6 class="bg-colour-blue " headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc3">1</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc2 dc6">1</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc7">1</TD><TD class=alignCenter headers="dr1 dr2 dc1 dc8">2 (40%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc3">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc2 dc6">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc7">0</TD><TD class=alignCenter headers="dr1 dr3 dc1 dc8">0</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc3">1</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc2 dc6">1</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc7">2</TD><TD class=alignCenter headers="dr1 dr4 dc1 dc8">3 (60%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc3">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc2 dc6">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc7">0</TD><TD class=alignCenter headers="dr1 dr5 dc1 dc8">0</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc3">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc4">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc5">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc2 dc6">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc7">0</TD><TD class=alignCenter headers="dr1 dr6 dc1 dc8">0</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignCenter headers="dr1 dr7 dc1 dc2 dc3">2</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr7 dc1 dc2 dc4">0</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr7 dc1 dc2 dc5">0</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr7 dc1 dc2 dc6">2</TD><TD class=alignCenter headers="dr1 dr7 dc1 dc7">3</TD><TD class=alignCenter headers="dr1 dr7 dc1 dc8">5</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignCenter headers="dr1 dr8 dc1 dc2 dc3">40.0%</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr8 dc1 dc2 dc4">0.0%</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr8 dc1 dc2 dc5">0.0%</TD><TD class="bg-colour-blue alignCenter" headers="dr1 dr8 dc1 dc2 dc6">100.0%</TD><TD class=alignCenter headers="dr1 dr8 dc1 dc7">60.0%</TD><TD class=alignCenter headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to November 2, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class="bg-colour-blue " headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class="bg-colour-blue " headers="ec1 ec2">A(H3) </TH><TH id=ec6 class="bg-colour-blue " headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignCenter headers="er1 er2 ec1 ec2 ec3">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec2 ec6">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er2 ec1 ec8">0</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignCenter headers="er1 er3 ec1 ec2 ec3">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec2 ec6">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er3 ec1 ec8">0</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignCenter headers="er1 er4 ec1 ec2 ec3">3</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec5">1</TD><TD class=alignCenter headers="er1 er4 ec1 ec2 ec6">2</TD><TD class=alignCenter headers="er1 er4 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er4 ec1 ec8">3 (50%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignCenter headers="er1 er5 ec1 ec2 ec3">3</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec4">0</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec5">0</TD><TD class=alignCenter headers="er1 er5 ec1 ec2 ec6">3</TD><TD class=alignCenter headers="er1 er5 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er5 ec1 ec8">3 (50%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignCenter headers="er1 er6 ec1 ec2 ec3">6</TD><TD class="bg-colour-blue alignCenter" headers="er1 er6 ec1 ec2 ec4">0</TD><TD class="bg-colour-blue alignCenter" headers="er1 er6 ec1 ec2 ec5">1</TD><TD class="bg-colour-blue alignCenter" headers="er1 er6 ec1 ec2 ec6">5</TD><TD class=alignCenter headers="er1 er6 ec1 ec7">0</TD><TD class=alignCenter headers="er1 er6 ec1 ec8">6</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>%<SUP>1</SUP> </TH><TD class=alignCenter headers="er1 er7 ec1 ec2 ec3">100%</TD><TD class="bg-colour-blue alignCenter" headers="er1 er7 ec1 ec2 ec4">0%</TD><TD class="bg-colour-blue alignCenter" headers="er1 er7 ec1 ec2 ec5">17%</TD><TD class="bg-colour-blue alignCenter" headers="er1 er7 ec1 ec2 ec6">83%</TD><TD class=alignCenter headers="er1 er7 ec1 ec7">0%</TD><TD class=alignCenter headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 44, four new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories.* The cases were as follows: two adults 45-64 years of age, both with influenza A(H3N2), and two adults ≥65 years of age with influenza A(H3N2) and influenza A(unsubtyped). No ICU admissions or deaths were reported.
    To date this season, 17 influenza-associated hospitalizations have been reported, of which 12 (70.6%) had influenza A (Table 6). Consistent with the data from IMPACT and PCIRN-SOS, there is a greater proportion of cases of influenza B among children under 5 years of age, whereas influenza A is predominant among adults over 45 years of age. One ICU admission was reported in an adult 45-64 years of age and no deaths have been reported. It is important to note that the cause of death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Data from the Aggregate Surveillance System may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to November 2, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=bg-colour-blue headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=bg-colour-blue headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=bg-colour-blue headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=8><SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.</TD></TR></TFOOT><TBODY></TBODY></TABLE>

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 43

    FluWatch report: October 20 to 26, 2013 (Week 43)

    Posted 2013-11-01For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w43_13/pdf/fw2013-43-eng.pdf">FluWatch report: October 20 to 26, 2013 (Week 43) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 291 <ABBR title=Kilobytes>KB</ABBR> - 10 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada increased slightly in week 43.
    • While rhinovirus and parainfluenza continued to be the predominant respiratory viruses in circulation in week 43, laboratory detections of influenza increased.
    • Both paediatric and adult hospitalizations with influenza were reported in week 43.
    • After increasing in late September, the ILI consultation rate has been stable in weeks 40-43.
    Note: The presentation of the FluWatch report has been updated for the 2013-14 influenza season in order to improve the readability and interpretation of the report. Graphs and tables related to influenza activity levels, laboratory data and ILI data have been modified. Additional graphs and tables were added to the sections related to surveillance of antiviral prescriptions and hospitalizations with influenza.

    Influenza/ILI Activity (geographic spread)

    In week 43, seven regions (in BC(1), AB(2), ON(2) and QC(2)) reported sporadic activity (Figure 1). The number of regions reporting sporadic activity has increased over the past two weeks.
    Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 43





    Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada

    Top of Page

    Influenza and Other Respiratory Virus Detections

    The number of positive influenza tests increased from a range of 3 to 7 over weeks 35 to 42, to 21 in week 43. The percentage of positive influenza tests increased slightly from 0.2% in week 42 to 1.0% in week 43 (Figure 2). Among the 21 influenza viruses detected in week 43, 62% were influenza A. Cumulative influenza virus detections by type/subtype to date have been predominantly influenza A (72%) with a nearly equal mix of A(H3) and A(H1N1)pdm09 among those subtyped (Table 1). Detailed information on age and type/subtype has been received for 49 cases to date this season. The majority of cases have been adults 45-64 years of age (49%), followed by children under 5 years of age (22%) (Table 2).
    Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14

    Text equivalent for figure 2Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2013-14
    The number of positive tests for both rhinovirus and parainfluenza declined in week 43, although they remained the predominant viruses detected. The number of positive tests for both adenovirus and RSV increased slightly. The numbers of positive tests for human metapneumovirus and coronavirus remained low in week 43 (Figure 3).
    For more details, see the weekly Respiratory Virus Detections in Canada Report.
    Figure 3. Number of positive laboratory tests for other respiratory viruses by report week, Canada, 2013-14


    Top of Page

    RSV: Respiratory syncytial virus; hMPV: Human metapneumovirus
    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly and cumulative numbers of positive influenza specimens
    by type, subtype and province, Canada, 2013-14
    </CAPTION><TBODY><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces <SUP>1</SUP></TH><TH id=ac1 colSpan=5>Weekly
    (October 20 to October 26, 2013)
    </TH><TH id=ac8 colSpan=5>Cumulative
    (August 25, 2013 to October 26, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=4 headers=ac1>Influenza A</TH><TH id=ac7 headers=ac1>B</TH><TH id=ac9 colSpan=4 headers=ac8>Influenza A</TH><TH id=ac14 headers=ac8>B</TH></TR><TR class=bg-colour-grey-light><TH id=ac3 headers="ac1 ac2">A Total</TH><TH id=ac4 class=bg-colour-orange headers="ac1 ac2">A(H1)pdm09</TH><TH id=ac5 class=bg-colour-orange headers="ac1 ac2">A(H3)</TH><TH id=ac6 class=bg-colour-orange headers="ac1 ac2">A(UnS)</TH><TD class=alignCenter headers="ac1 ac7">B Total</TD><TH id=ac10 headers="ac8 ac9">A Total</TH><TH id=ac11 class=bg-colour-orange headers="ac8 ac9">A(H1)pdm09</TH><TH id=ac12 class=bg-colour-orange headers="ac8 ac9">A(H3)</TH><TH id=ac13 class=bg-colour-orange headers="ac8 ac9">A(UnS)</TH><TD class=alignCenter headers="ac8 ac14">B Total</TD></TR><TR><TH id=ar2 class=alignLeft headers=ar1>BC</TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">1</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac10">1</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac11">0</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac12">1</TD><TD class=alignRight headers="ar1 ar2 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar2 ac8 ac14">3</TD></TR><TR><TH id=ar3 class=alignLeft headers=ar1>AB</TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">5</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">1</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">3</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">1</TD><TD class=alignRight headers="ar1 ar3 ac1 ac7">5</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac10">14</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac11">9</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac12">4</TD><TD class=alignRight headers="ar1 ar3 ac8 ac9 ac13">1</TD><TD class=alignRight headers="ar1 ar3 ac8 ac14">7</TD></TR><TR><TH id=ar4 class=alignLeft headers=ar1>SK</TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac10">2</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac11">0</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar4 ac8 ac9 ac13">2</TD><TD class=alignRight headers="ar1 ar4 ac8 ac14">0</TD></TR><TR><TH id=ar5 class=alignLeft headers=ar1>MB</TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac10">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac11">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar5 ac8 ac14">0</TD></TR><TR><TH id=ar6 class=alignLeft headers=ar1>ON</TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">5</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">5</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar6 ac1 ac7">3</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac10">14</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac11">3</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac12">8</TD><TD class=alignRight headers="ar1 ar6 ac8 ac9 ac13">3</TD><TD class=alignRight headers="ar1 ar6 ac8 ac14">6</TD></TR><TR><TH id=ar7 class=alignLeft headers=ar1>QC</TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">2</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">2</TD><TD class=alignRight headers="ar1 ar7 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac10">9</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac11">0</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar7 ac8 ac9 ac13">9</TD><TD class=alignRight headers="ar1 ar7 ac8 ac14">0</TD></TR><TR><TH id=ar8 class=alignLeft headers=ar1>NB</TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac10">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac11">1</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar8 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar8 ac8 ac14">0</TD></TR><TR><TH id=ar9 class=alignLeft headers=ar1>NS</TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac10">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac11">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar9 ac8 ac14">0</TD></TR><TR><TH id=ar10 class=alignLeft headers=ar1>PE</TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac10">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac11">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar10 ac8 ac14">0</TD></TR><TR><TH id=ar11 class=alignLeft headers=ar1>NL</TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac7">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac10">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac11">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac9 ac13">0</TD><TD class=alignRight headers="ar1 ar11 ac8 ac14">0</TD></TR><TR><TH id=ar12 class=alignLeft headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">13</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar12 ac1 ac2 ac4">1</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar12 ac1 ac2 ac5">9</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar12 ac1 ac2 ac6">3</TD><TD class=alignRight headers="ar1 ar12 ac1 ac7">8</TD><TD class=alignRight headers="ar1 ar12 ac8 ac9 ac10">41</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar12 ac8 ac9 ac11">13</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar12 ac8 ac9 ac12">13</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar12 ac8 ac9 ac13">15</TD><TD class=alignRight headers="ar1 ar12 ac8 ac14">16</TD></TR><TR><TH id=ar13 class=alignLeft headers=ar1>Percentage <SUP>2</SUP></TH><TD class=alignRight headers="ar1 ar13 ac1 ac2 ac3">61.9%</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar13 ac1 ac2 ac4">7.7%</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar13 ac1 ac2 ac5">69.2%</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar13 ac1 ac2 ac6">23.1%</TD><TD class=alignRight headers="ar1 ar13 ac1 ac7">38.1%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac9 ac10">71.9%</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar13 ac8 ac9 ac11">31.7%</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar13 ac8 ac9 ac12">31.7%</TD><TD class="alignRight bg-colour-orange" headers="ar1 ar13 ac8 ac9 ac13">36.6%</TD><TD class=alignRight headers="ar1 ar13 ac8 ac14">28.1%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 2. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reporting<SUP>3</SUP>, Canada, 2013-14</CAPTION><TBODY><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups (years)</TH><TH id=bc1 colSpan=5>Weekly
    (October 20 to October 26, 2013)
    </TH><TH id=bc8 colSpan=7>Cumulative
    (August 25, 2013 to October 26, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH><TH id=bc15 colSpan=2 headers=bc8>Influenza A and B</TH></TR><TR class=bg-colour-grey-light><TH id=bc3 headers="bc1 bc2">A Total</TH><TH id=bc4 class=bg-colour-orange headers="bc1 bc2">A(H1) pdm09</TH><TH id=bc5 class=bg-colour-orange headers="bc1 bc2">A(H3)</TH><TH id=bc6 class=bg-colour-orange headers="bc1 bc2">A (UnS)</TH><TD class=alignCenter headers="bc1 bc7">Total</TD><TH id=bc10 headers="bc8 bc9">A Total</TH><TH id=bc11 class=bg-colour-orange headers="bc8 bc9">A(H1) pdm09</TH><TH id=bc12 class=bg-colour-orange headers="bc8 bc9">A(H3)</TH><TH id=bc13 class=bg-colour-orange headers="bc8 bc9">A (UnS)</TH><TD class=alignCenter headers="bc8 bc14">Total</TD><TH id=bc16 headers="bc8 bc15">#</TH><TH id=bc17 headers="bc8 bc15">%</TH></TR><TR><TH id=br2 class=alignLeft headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">1 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">0 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">1 </TD><TD class=alignRight headers="br1 br2 bc1 bc7">2 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">7 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">2 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">2 </TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">3 </TD><TD class=alignRight headers="br1 br2 bc8 bc14">4 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc16">11 </TD><TD class=alignRight headers="br1 br2 bc8 bc15 bc17">22.4% </TD></TR><TR><TH id=br3 class=alignLeft headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">2 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">2 </TD><TD class=alignRight headers="br1 br3 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">2 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">0 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">0 </TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">2 </TD><TD class=alignRight headers="br1 br3 bc8 bc14">1 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc16">3 </TD><TD class=alignRight headers="br1 br3 bc8 bc15 bc17">6.1% </TD></TR><TR><TH id=br4 class=alignLeft headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">1 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">1 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br4 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">4 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">1 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">1 </TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">2 </TD><TD class=alignRight headers="br1 br4 bc8 bc14">1 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc16">5 </TD><TD class=alignRight headers="br1 br4 bc8 bc15 bc17">10.2% </TD></TR><TR><TH id=br5 class=alignLeft headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">7 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">0 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">6 </TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">1 </TD><TD class=alignRight headers="br1 br5 bc1 bc7">2 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">19 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">8 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">8 </TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">3 </TD><TD class=alignRight headers="br1 br5 bc8 bc14">5 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc16">24 </TD><TD class=alignRight headers="br1 br5 bc8 bc15 bc17">49.0% </TD></TR><TR><TH id=br6 class=alignLeft headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">1 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">1 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br6 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">4 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">1 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">1 </TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">2 </TD><TD class=alignRight headers="br1 br6 bc8 bc14">2 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc16">6 </TD><TD class=alignRight headers="br1 br6 bc8 bc15 bc17">12.2% </TD></TR><TR><TH id=br7 class=alignLeft headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignRight headers="br1 br7 bc1 bc7">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc14">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc16">0 </TD><TD class=alignRight headers="br1 br7 bc8 bc15 bc17">0.0% </TD></TR><TR><TH id=br8 class=alignLeft headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">12 </TD><TD class="alignRight bg-colour-orange" headers="br1 br8 bc1 bc2 bc4">2 </TD><TD class="alignRight bg-colour-orange" headers="br1 br8 bc1 bc2 bc5">6 </TD><TD class="alignRight bg-colour-orange" headers="br1 br8 bc1 bc2 bc6">4 </TD><TD class=alignRight headers="br1 br8 bc1 bc7">4 </TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">36 </TD><TD class="alignRight bg-colour-orange" headers="br1 br8 bc8 bc9 bc11">12 </TD><TD class="alignRight bg-colour-orange" headers="br1 br8 bc8 bc9 bc12">12 </TD><TD class="alignRight bg-colour-orange" headers="br1 br8 bc8 bc9 bc13">12 </TD><TD class=alignRight headers="br1 br8 bc8 bc14">13 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc16">49 </TD><TD class=alignRight headers="br1 br8 bc8 bc15 bc17">100.0% </TD></TR><TR><TH id=br9 class=alignLeft headers=br1>Percentage<SUP>2</SUP></TH><TD class=alignRight headers="br1 br9 bc1 bc2 bc3">75.0% </TD><TD class="alignRight bg-colour-orange" headers="br1 br9 bc1 bc2 bc4">16.7% </TD><TD class="alignRight bg-colour-orange" headers="br1 br9 bc1 bc2 bc5">50.0% </TD><TD class="alignRight bg-colour-orange" headers="br1 br9 bc1 bc2 bc6">33.3% </TD><TD class=alignRight headers="br1 br9 bc1 bc7">25.0% </TD><TD class=alignRight headers="br1 br9 bc8 bc9 bc10">73.5% </TD><TD class="alignRight bg-colour-orange" headers="br1 br9 bc8 bc9 bc11">33.3% </TD><TD class="alignRight bg-colour-orange" headers="br1 br9 bc8 bc9 bc12">33.3% </TD><TD class="alignRight bg-colour-orange" headers="br1 br9 bc8 bc9 bc13">33.3% </TD><TD class=alignRight headers="br1 br9 bc8 bc14">26.5% </TD><TD class=alignRight></TD><TD class=alignRight></TD></TR></TBODY></TABLE>
    1 Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.
    2 Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    3 Table 2 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.


    Top of Page

    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized six influenza viruses [two A(H3N2), two A(H1N1)pdm09 and two influenza B]. All viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine (Figure 4).
    Figure 4. Influenza strain characterizations, Canada, 2013-14, N =6

    The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.
    The recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus (Yamagata lineage).


    Text equivalent for figure 4Influenza strain characterizations, Canada, 2013-2014, N =3

    Top of Page

    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested six influenza viruses for resistance to oseltamivir and zanamivir, and all were sensitive. Four influenza A viruses were tested for amantadine resistance, and all were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">2</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">2</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">2</TD><TD class=alignCenter headers="cr2 cc9">2(100%)</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">2</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">2</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">2</TD><TD class=alignCenter headers="cr3 cc9">2(100%)</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">2</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">2</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">6</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">6</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">4</TD><TD class=alignCenter headers="cr5 cc9">4(100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased slightly from 23.4/1,000 in week 42 to 20.4/1,000 in week 43 (Figure 5).
    Figure 5. Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Note: No data available for mean rate for weeks 19 to 39 for the 1996-1997 through 2002-2003 seasons. Delays in the reporting of data may cause data to change retrospectively. The calculation of the average ILI consultation rate over 17 seasons was aligned with influenza activity in each season. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. The number of sentinel physicians in each province or territory is as follows: BC(21), AB(80), SK(11), MB(18), ON(169), QC(14), NB(29), NS(26), PE(4), NL(16), NU(1), NT(14), YT(13). Not all sentinel physicians report every week.
    Text equivalent for figure 5Influenza-like-illness (ILI) consultation rates by report week, compared to the 1996-97 through to 2012-13 seasons (with pandemic data suppressed), Canada, 2013-2014

    Top of Page

    Influenza Outbreak Surveillance

    No new influenza outbreaks were reported in week 43 (Figure 6).
    Figure 6. Overall number of new influenza outbreaks by report week, Canada, 2013-2014

    1 All provinces and territories except NU report outbreaks in long-term care facilities. All provinces and territories with the exception of NU and QC report outbreaks in hospitals. Outbreaks of influenza or influenza-like-illness in other facilities are reported to FluWatch but reporting varies between jurisdictions. Outbreak definitions are included at the end of the report.
    Text equivalent for figure 6 Overall number of new influenza outbreaks by report week, Canada, 2013-2014
    Pharmacy Surveillance

    Pharmacy surveillance for sales of influenza antivirals has not yet begun for the 2013-14 influenza season (Figure 7).
    Figure 7. Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Note: Pharmacy sales data are provided to the Public Health Agency of Canada by Rx Canada Inc. and sourced from major retail drug chains representing over 3,000 stores nationwide (excluding Nunavut) in 85% of Health Regions. Data provided include the number of new antiviral prescriptions (for Tamiflu and Relenza) and the total number of new prescriptions dispensed by Province/Territory and age group. Age-groups: Infant: 0-2y, Child: 2-18y; Adult: 19-64y, Senior: ≥65y.
    Text equivalent for figure 7Proportion of prescription sales for influenza antivirals by age-group and week, Canada, 2013-14

    Top of Page

    Sentinel Hospital Influenza Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    In week 43, two laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations were reported by the Immunization Monitoring Program Active (IMPACT) network: one child 0-5 months of age and one 2-4 years of age, both with influenza B (Figure 8a).
    To date this season, a total of five influenza-associated paediatric hospitalizations have been reported by the IMPACT network: two children 0-5 months of age and three 2-4 years of age. One ICU admission was required in a child 2-4 years of age with influenza B. No deaths have been reported (Figure 9a and Table 4).
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network will begin on November 15th 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance. Two new hospitalizations were reported in week 43, one 45-64 years of age and one ≥65 years of age, both with influenza A. No ICU admissions or deaths were reported in week 43 (Figure 8b).
    To date this season, five influenza-associated hospitalizations have been reported by the PCIRN-SOS network, all adults over 45 years of age with influenza A. ICU admission was required for one hospitalization and no deaths have been reported (Figure 9b and Table 5).
    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 4 - Cumulative numbers of paediatric hospitalizations with influenza reported by the IMPACT network, Canada, 2013-14</CAPTION><TBODY><TR class=bg-colour-yellow><TH id=dr1 rowSpan=3>Age groups </TH><TH id=dc1 colSpan=6>Cumulative (Aug. 25, 2013 to October 26, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=dc2 colSpan=4 headers=dc1>Influenza A </TH><TH id=dc7 headers=dc1>B </TH><TH id=dc8 headers=dc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=dc3 headers="dc1 dc2">A Total </TH><TH id=dc4 class=bg-colour-orange headers="dc1 dc2">A(H1) pdm09 </TH><TH id=dc5 class=bg-colour-orange headers="dc1 dc2">A(H3) </TH><TH id=dc6 class=bg-colour-orange headers="dc1 dc2">A (UnS) </TH><TD class=alignCenter headers="dc1 dc7">Total</TD><TD class=alignCenter headers="dc1 dc8"># (%)</TD></TR><TR><TH id=dr2 class=alignLeft headers=dr1>0-5m </TH><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc3">1</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc4">0</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr2 dc1 dc2 dc6">1</TD><TD class=alignRight headers="dr1 dr2 dc1 dc7">1</TD><TD class=alignRight headers="dr1 dr2 dc1 dc8">2 (40%)</TD></TR><TR><TH id=dr3 class=alignLeft headers=dr1>6-23m </TH><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc3">0</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc4">0</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr3 dc1 dc2 dc6">0</TD><TD class=alignRight headers="dr1 dr3 dc1 dc7">0</TD><TD class=alignRight headers="dr1 dr3 dc1 dc8">0</TD></TR><TR><TH id=dr4 class=alignLeft headers=dr1>2-4y </TH><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc3">1</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc4">0</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr4 dc1 dc2 dc6">1</TD><TD class=alignRight headers="dr1 dr4 dc1 dc7">2</TD><TD class=alignRight headers="dr1 dr4 dc1 dc8">3 (60%)</TD></TR><TR><TH id=dr5 class=alignLeft headers=dr1>5-9y </TH><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc3">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc4">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc2 dc6">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc7">0</TD><TD class=alignRight headers="dr1 dr5 dc1 dc8">0</TD></TR><TR><TH id=dr6 class=alignLeft headers=dr1>10-16y </TH><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc3">0</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc4">0</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc5">0</TD><TD class=alignRight headers="dr1 dr6 dc1 dc2 dc6">0</TD><TD class=alignRight headers="dr1 dr6 dc1 dc7">0</TD><TD class=alignRight headers="dr1 dr6 dc1 dc8">0</TD></TR><TR><TH id=dr7 class=alignLeft headers=dr1>Total </TH><TD class=alignRight headers="dr1 dr7 dc1 dc2 dc3">2</TD><TD class="alignRight bg-colour-orange" headers="dr1 dr7 dc1 dc2 dc4">0</TD><TD class="alignRight bg-colour-orange" headers="dr1 dr7 dc1 dc2 dc5">0</TD><TD class="alignRight bg-colour-orange" headers="dr1 dr7 dc1 dc2 dc6">2</TD><TD class=alignRight headers="dr1 dr7 dc1 dc7">3</TD><TD class=alignRight headers="dr1 dr7 dc1 dc8">5</TD></TR><TR><TH id=dr8 class=alignLeft headers=dr1>% <SUP>1</SUP> </TH><TD class=alignRight headers="dr1 dr8 dc1 dc2 dc3">40.0%</TD><TD class="alignRight bg-colour-orange" headers="dr1 dr8 dc1 dc2 dc4">0.0%</TD><TD class="alignRight bg-colour-orange" headers="dr1 dr8 dc1 dc2 dc5">0.0%</TD><TD class="alignRight bg-colour-orange" headers="dr1 dr8 dc1 dc2 dc6">100.0%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc7">60.0%</TD><TD class=alignRight headers="dr1 dr8 dc1 dc8">100.0%</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 5 - Cumulative numbers of adult hospitalizations with influenza
    reported by the PCIRN-SOS network, Canada, 2013-14
    </CAPTION><TBODY><TR class=bg-colour-yellow><TH id=er1 rowSpan=3>Age groups </TH><TH id=ec1 class=noWrap colSpan=6>Cumulative (Aug. 25, 2013 to October 26, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=ec2 colSpan=4 headers=ec1>Influenza A </TH><TH id=ec7 headers=ec1>B </TH><TH id=ec8 headers=ec1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=ec3 headers="ec1 ec2">A Total </TH><TH id=ec4 class=bg-colour-orange headers="ec1 ec2">A(H1) pdm09 </TH><TH id=ec5 class=bg-colour-orange headers="ec1 ec2">A(H3) </TH><TH id=ec6 class=bg-colour-orange headers="ec1 ec2">A(UnS) </TH><TD class=alignCenter headers="ec1 ec7">Total</TD><TD class=alignCenter headers="ec1 ec8"># (%)</TD></TR><TR><TH id=er2 class=alignLeft headers=er1>16-20 </TH><TD class=alignRight headers="er1 er2 ec1 ec2 ec3">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er2 ec1 ec2 ec6">0</TD><TD class=alignRight headers="er1 er2 ec1 ec7">0</TD><TD class=alignRight headers="er1 er2 ec1 ec8">0</TD></TR><TR><TH id=er3 class=alignLeft headers=er1>20-44 </TH><TD class=alignRight headers="er1 er3 ec1 ec2 ec3">0</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er3 ec1 ec2 ec6">0</TD><TD class=alignRight headers="er1 er3 ec1 ec7">0</TD><TD class=alignRight headers="er1 er3 ec1 ec8">0</TD></TR><TR><TH id=er4 class=alignLeft headers=er1>45-64 </TH><TD class=alignRight headers="er1 er4 ec1 ec2 ec3">3</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec5">1</TD><TD class=alignRight headers="er1 er4 ec1 ec2 ec6">2</TD><TD class=alignRight headers="er1 er4 ec1 ec7">0</TD><TD class=alignRight headers="er1 er4 ec1 ec8">3 (60%)</TD></TR><TR><TH id=er5 class=alignLeft headers=er1>65+ </TH><TD class=alignRight headers="er1 er5 ec1 ec2 ec3">2</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec4">0</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec5">0</TD><TD class=alignRight headers="er1 er5 ec1 ec2 ec6">2</TD><TD class=alignRight headers="er1 er5 ec1 ec7">0</TD><TD class=alignRight headers="er1 er5 ec1 ec8">2 (40%)</TD></TR><TR><TH id=er6 class=alignLeft headers=er1>Total </TH><TD class=alignRight headers="er1 er6 ec1 ec2 ec3">5</TD><TD class="bg-colour-orange alignRight" headers="er1 er6 ec1 ec2 ec4">0</TD><TD class="bg-colour-orange alignRight" headers="er1 er6 ec1 ec2 ec5">1</TD><TD class="bg-colour-orange alignRight" headers="er1 er6 ec1 ec2 ec6">4</TD><TD class=alignRight headers="er1 er6 ec1 ec7">0</TD><TD class=alignRight headers="er1 er6 ec1 ec8">5</TD></TR><TR><TH id=er7 class=alignLeft headers=er1>% </TH><TD class=alignRight headers="er1 er7 ec1 ec2 ec3">100%</TD><TD class="bg-colour-orange alignRight" headers="er1 er7 ec1 ec2 ec4">0%</TD><TD class="bg-colour-orange alignRight" headers="er1 er7 ec1 ec2 ec5">20%</TD><TD class="bg-colour-orange alignRight" headers="er1 er7 ec1 ec2 ec6">80%</TD><TD class=alignRight headers="er1 er7 ec1 ec7">0%</TD><TD class=alignRight headers="er1 er7 ec1 ec8">100%</TD></TR></TBODY></TABLE>
    <SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.
    Figure 8. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 8aNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 8bNumber of cases of influenza reported by sentinel hospital networks, by week, Canada, 2013-14: Adult hospitalizations (>16 year of age, PCIRN-SOS)
    Figure 9. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14
    A) Paediatric hospitalizations (≤16 years of age, IMPACT)

    Text equivalent for figure 9aPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Paediatric hospitalizations (≤16 years of age, IMPACT)
    B) Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Text equivalent for figure 9bPercentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2013-14: Adult hospitalizations (≥16 year of age, PCIRN-SOS)

    Top of Page

    Provincial/Territorial Influenza Hospitalizations and Deaths

    In week 43, six new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories. <SUP>*</SUP>The cases were as follows: two children 0-4 years of age, both with influenza B; one child 5-14 years of age with influenza B; two adults 45-64 years of age with influenza A(H3N2) and influenza A(unsubtyped); and one adult ≥65 years of age with influenza A(H1N1)pdm09. No ICU admissions or deaths were reported.
    To date this season, 13 influenza-associated hospitalizations have been reported, predominantly among children 0-4 years of age and adults 45-64 years of age (Table 6). There is no predominance of one influenza type or subtype among these cases to date. Consistent with the data from IMPACT and PCIRN-SOS, there is a greater proportion of cases of influenza B among children under 5 years of age compared to adults over 45 years of age. One ICU admission was reported in an adult 45-64 years of age and no deaths have been reported. It is important to note that the cause of death does not have to be attributable to influenza, a positive laboratory test is sufficient for reporting. Detailed clinical information (e.g. underlying medical conditions) is not known for these cases.
    * Note: Data from the Aggregate Surveillance System may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 6. Cumulative number of hospitalizations with influenza reported by the participating provinces and territories, Canada, 2013-14</CAPTION><TBODY><TR class=bg-colour-yellow><TH id=fr1 rowSpan=3>Age groups </TH><TH id=fc1 colSpan=6>Cumulative (Aug. 25, 2013 to October 26, 2013) </TH></TR><TR class=bg-colour-yellow><TH id=fc2 colSpan=4 headers=fc1>Influenza A </TH><TH id=fc7 headers=fc1>B </TH><TH id=fc8 headers=fc1>Influenza A and B </TH></TR><TR class=bg-colour-grey-light><TH id=fc3 headers="fc1 fc2">A Total </TH><TH id=fc4 class=bg-colour-orange headers="fc1 fc2">A(H1) pdm09 </TH><TH id=fc5 class=bg-colour-orange headers="fc1 fc2">A(H3) </TH><TH id=fc6 class=bg-colour-orange headers="fc1 fc2">A (UnS) </TH><TD class=alignCenter headers="fc1 fc7">Total</TD><TD class=alignCenter headers="fc1 fc8"># (%)</TD></TR><TR><TH id=fr2 class=alignLeft headers=fr1>0-4 years </TH><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc3">2</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc4">0</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc5">1</TD><TD class=alignRight headers="fr1 fr2 fc1 fc2 fc6">1</TD><TD class=alignRight headers="fr1 fr2 fc1 fc7">3</TD><TD class=alignRight headers="fr1 fr2 fc1 fc8">5 (38.5%)</TD></TR><TR><TH id=fr3 class=alignLeft headers=fr1>5-14 years </TH><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc3">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc4">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc2 fc6">0</TD><TD class=alignRight headers="fr1 fr3 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr3 fc1 fc8">1 (7.7%)</TD></TR><TR><TH id=fr4 class=alignLeft headers=fr1>15-19 years </TH><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc3">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc4">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc2 fc6">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr4 fc1 fc8">0</TD></TR><TR><TH id=fr5 class=alignLeft headers=fr1>20-44 years </TH><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc3">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc4">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc2 fc6">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr5 fc1 fc8">0</TD></TR><TR><TH id=fr6 class=alignLeft headers=fr1>45-64 years </TH><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc3">4</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc4">2</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc5">1</TD><TD class=alignRight headers="fr1 fr6 fc1 fc2 fc6">1</TD><TD class=alignRight headers="fr1 fr6 fc1 fc7">1</TD><TD class=alignRight headers="fr1 fr6 fc1 fc8">5 (38.5%)</TD></TR><TR><TH id=fr7 class=alignLeft headers=fr1>65+ years </TH><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc3">2</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc4">1</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc5">0</TD><TD class=alignRight headers="fr1 fr7 fc1 fc2 fc6">1</TD><TD class=alignRight headers="fr1 fr7 fc1 fc7">0</TD><TD class=alignRight headers="fr1 fr7 fc1 fc8">2 (15.4%)</TD></TR><TR><TH id=fr8 class=alignLeft headers=fr1>Total </TH><TD class=alignRight headers="fr1 fr8 fc1 fc2 fc3">8</TD><TD class="alignRight bg-colour-orange" headers="fr1 fr8 fc1 fc2 fc4">3</TD><TD class="alignRight bg-colour-orange" headers="fr1 fr8 fc1 fc2 fc5">2</TD><TD class="alignRight bg-colour-orange" headers="fr1 fr8 fc1 fc2 fc6">3</TD><TD class=alignRight headers="fr1 fr8 fc1 fc7">5</TD><TD class=alignRight headers="fr1 fr8 fc1 fc8">13</TD></TR><TR><TH id=fr9 class=alignLeft headers=fr1>Percentage <SUP>1</SUP> </TH><TD class=alignRight headers="fr1 fr9 fc1 fc2 fc3">61.5%</TD><TD class="alignRight bg-colour-orange" headers="fr1 fr9 fc1 fc2 fc4">37.5%</TD><TD class="alignRight bg-colour-orange" headers="fr1 fr9 fc1 fc2 fc5">25.0%</TD><TD class="alignRight bg-colour-orange" headers="fr1 fr9 fc1 fc2 fc6">37.5%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc7">38.5%</TD><TD class=alignRight headers="fr1 fr9 fc1 fc8">100%</TD></TR></TBODY></TABLE>
    <SUP>1</SUP> Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.
    UnS: unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 42

    FluWatch report: October 13 to 19, 2013 (Week 42)

    Posted 2013-10-25For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w42_13/pdf/fw2013-42-eng.pdf">FluWatch report: October 13 to 19, 2013 (Week 42) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 113 <ABBR title=Kilobytes>KB</ABBR> - 8 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada remained at inter-seasonal levels in week 42.
    • Few laboratory detections of influenza have been reported to date this season; rhinovirus and parainfluenza were the predominant respiratory viruses in circulation in week 42.
    • The ILI consultation rate has followed a gradual upward trend over the past five weeks.
    Influenza Activity (geographic spread) and Outbreaks

    In week 42, five regions (in AB(3), ON and QC) reported sporadic activity (Figure 1). Localized activity has not been reported since week 26 of the 2012-13 season (Figure 2). No new influenza outbreaks were reported in week 42 (Figure 3).
    Figure 1. Map of overall Influenza activity level by province and territory, Canada, Week 42





    Note: Influenza activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates (see graphs and tables) and reported outbreaks. Please refer to detailed definitions on the last page. For areas where no data is reported, late reports from these provinces and territories will appear on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Figure 2. Number of influenza surveillance regions<SUP title="sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in">?</SUP> reporting widespread or localized influenza activity, Canada, by report week, 2013-2014 (N<SUP>*</SUP>=58)


    ?sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.
    * Total number of influenza surveillance regions in Canada
    Text equivalent for figure 2Number of influenza surveillance regions reporting widespread or localized influenza activity, Canada, by report week, 2011-2012 (N=56)
    Figure 3. Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014


    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2011-2012

    Top of Page

    Influenza and Other Respiratory Virus Detections

    The overall percentage of positive influenza tests was low and stable, at 0.2% in week 42. Among the three influenza viruses detected in week 42, all were influenza A (Table 1). Cumulative influenza virus detections by type/subtype to date are as follows: 78% influenza A [14% A(H3), 39% A(H1N1)pdm09 and 46% A(unsubtyped)] and 22% influenza B (Table 1).
    Detailed information on age and type/subtype has been received for 29 cases to date this season (Table 2). The proportion of cases by age group is as follows: 20.7% <5 years; 0% between 5-19 years; 17.2% between 20-44 years; 44.8% between 45-64 years; and 17.2% ≥65 years of age.
    The percentage of positive tests for rhinovirus was similar to week 41, at 31.0% in week 42. The percentage of positive tests for parainfluenza increased slightly from 4.1% in week 41 to 5.5% in week 42. The percentages of positive tests for other respiratory viruses were low in week 42: human metapneumovirus (hMPV) (0.1%), respiratory syncytial virus (RSV) (0.6%), coronavirus (0.6%) and adenovirus (1.7%) (Figure 5)<SUP>*</SUP>.
    * For more details, see the weekly Respiratory Virus Detections in Canada Report.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly & Cumulative numbers of positive influenza specimens
    by Provincial Laboratories, Canada, 2013-2014
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces</TH><TH id=ac1 colSpan=6>Weekly
    (October 13 to 19, 2013)
    </TH><TH id=ac9 colSpan=6>Cumulative
    (August 25, 2013 to October 19, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=5 headers=ac1>Influenza A</TH><TH id=ac8 headers=ac1>Influenza
    B
    </TH><TH id=ac10 colSpan=5 headers=ac9>Influenza A</TH><TH id=ac16 headers=ac9>Influenza
    B
    </TH></TR><TR class=bg-colour-yellow><TH id=ac3 headers=ac2>A Total</TH><TH id=ac4 headers=ac2>A(H1)</TH><TH id=ac5 headers=ac2>A(H3)</TH><TH id=ac6 headers=ac2>Pand H1N1</TH><TH id=ac7 class=noWrap headers=ac2>A
    ( <ABBR title=unsubtyped>Un S</ABBR>)Table 1 note*
    </TH><TH headers="ac1 ac8">Total</TH><TH id=ac11 headers=ac10>A Total</TH><TH id=ac12 headers=ac10>A(H1)</TH><TH id=ac13 headers=ac10>A(H3)</TH><TH id=ac14 headers=ac10>Pand H1N1</TH><TH id=ac15 class=noWrap headers=ac10>A
    (Un S) Table 1 note*
    </TH><TH headers=ac16>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13>* Unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available. Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Note: Weekly data is based on week of positive lab detection. Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals. </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=bg-colour-yellow headers=ar1><ABBR title="British Columbia ">BC</ABBR></TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac16">3 </TD></TR><TR><TH id=ar3 class=bg-colour-yellow headers=ar1><ABBR title=Alberta>AB</ABBR></TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac11">9 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac13">1 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac14">7 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac15">1 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac16">2 </TD></TR><TR><TH id=ar4 class=bg-colour-yellow headers=ar1><ABBR title=Saskatchewan>SK</ABBR></TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac11">2 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac15">2 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac16">0 </TD></TR><TR><TH id=ar5 class=bg-colour-yellow headers=ar1><ABBR title=Manitoba>MB</ABBR></TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac16">0 </TD></TR><TR><TH id=ar6 class=bg-colour-yellow headers=ar1><ABBR title=Ontario>ON</ABBR></TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac11">9 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac13">3 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac14">3 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac15">3 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac16">3 </TD></TR><TR><TH id=ar7 class=bg-colour-yellow headers=ar1><ABBR title=Quebec>QC</ABBR></TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac11">7 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac15">7 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac16">0 </TD></TR><TR><TH id=ar8 class=bg-colour-yellow headers=ar1><ABBR title="New Brunswick">NB</ABBR></TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac11">1 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac14">1 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac16">0 </TD></TR><TR><TH id=ar9 class=bg-colour-yellow headers=ar1><ABBR title="Nova Scotia ">NS</ABBR></TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac16">0 </TD></TR><TR><TH id=ar10 class=bg-colour-yellow headers=ar1><ABBR title="Prince Edward Island ">PE</ABBR></TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac16">0 </TD></TR><TR><TH id=ar11 class=bg-colour-yellow headers=ar1><ABBR title="Newfoundland/Labrador ">NL</ABBR></TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac16">0 </TD></TR><TR><TH id=ar12 class=bg-colour-yellow headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">3 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac7">3 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac11">28 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac13">4 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac14">11 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac15">13 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac16">8 </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 2. Weekly & Cumulative numbers of positive influenza specimens by age groups
    reported through case-based laboratory reporting, Canada, 2013-2014 Table 2 note*
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups</TH><TH id=bc1 colSpan=5>Weekly
    (October 13 to 19, 2013)
    </TH><TH id=bc8 colSpan=5>Cumulative
    (August 25, 2013 to October 19, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH></TR><TR class=bg-colour-yellow><TH id=bc3 headers=bc2>A Total</TH><TH id=bc4 headers=bc2>Pandemic H1N1</TH><TH id=bc5 headers=bc2>A/H3N2</TH><TH id=bc6 headers=bc2>A unsubtyped</TH><TH headers="bc1 bc7">Total</TH><TH id=bc10 headers=bc9>A Total</TH><TH id=bc11 headers=bc9>Pandemic H1N1</TH><TH id=bc12 headers=bc9>A/H3N2</TH><TH id=bc13 headers=bc9>A unsubtyped</TH><TH headers=bc14>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11>* Please note that this table reflects the number of specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported. Delays in the reporting of data may cause data to change retrospectively.</TD></TR></TFOOT><TBODY><TR><TH id=br2 headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">6 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">1 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">2 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">3 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">0 </TD></TR><TR><TH id=br3 headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">0 </TD></TR><TR><TH id=br4 headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">4 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">1 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">2 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">1 </TD></TR><TR><TH id=br5 headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">10 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">8 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">2 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">3 </TD></TR><TR><TH id=br6 headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">3 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">2 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">2 </TD></TR><TR><TH id=br7 headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">0 </TD></TR><TR><TH id=br8 headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">2 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc6">2 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">23 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc11">10 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc12">4 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc13">9 </TD><TD class=alignCenter headers="br1 br8 bc8 bc14">6 </TD></TR></TBODY></TABLE>


    Top of Page

    Figure 4. Influenza tests reported and percentage of tests positive,
    by report week, Canada, 2013-2014


    Text equivalent for figure 4Influenza tests reported and percentage of tests positive, Canada, by report week, 2011-2012
    Figure 5. Percent positive influenza tests, compared to other respiratory viruses,
    by reporting week, Canada, 2013-2014


    Text equivalent for figure 5Percent positive influenza tests, compared to other respiratory viruses, Canada, by reporting week, 2011-2012

    Top of Page


    Influenza Strain Characterizations

    During the 2013-2014 influenza season, the National Microbiology Laboratory (NML) has antigenically characterized three influenza viruses [one A(H3N2), one A(H1N1)pdm09 and one influenza B]. All viruses were similar to the strains recommended by the WHO for the 2013-14 seasonal influenza vaccine (Figure 6).

    Figure 6. Influenza strain characterizations, Canada, 2013-2014, N =3

    Note: The WHO recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus.
    Text equivalent for figure 6Influenza strain characterizations, Canada, 2011-2012

    Top of Page


    Antiviral Resistance

    During the 2013-2014 influenza season, NML has tested three influenza viruses for resistance to oseltamivir and zanamivir, and all were sensitive. Two influenza A viruses were tested for amantadine resistance, and both were resistant (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">1</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">1</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">1</TD><TD class=alignCenter headers="cr2 cc9">1(100%)</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">1</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">1</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">1</TD><TD class=alignCenter headers="cr3 cc9">1(100%)</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">1</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">1</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">3</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">3</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">2</TD><TD class=alignCenter headers="cr5 cc9">2(100%)</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased slightly from 22.4/1,000 in week 41 to 24.2/1,000 in week 42 (Figure 7).
    Figure 7. Influenza-like illness (ILI) consultation rates, by report week, Canada, 2013-2014 compared to 1996/97 through to 2011/12 seasons (with pandemic data suppressed)

    Note: No data available for mean rate in previous years for weeks 19 to 39 (1996-1997 through 2002-2003 seasons). Delays in the reporting of data may cause data to change retrospectively.
    Text equivalent for figure 7Influenza-like illness (ILI) consultation rates, Canada, by report week, 2011-2012 compared to 1996/97 through to 2010/11 seasons (with pandemic data suppressed)

    Top of Page


    Severe Respiratory Illness Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)

    In week 42, one laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalization was reported by the Immunization Monitoring Program Active (IMPACT) network: a child 2-4 years of age with influenza A(unsubtyped).

    To date this season, a total of two influenza-associated paediatric hospitalizations have been reported by the IMPACT network. The previous case was a child 2-4 years of age, hospitalized in week 41 with influenza B for whom ICU admission was required. No deaths have been reported.

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Adult Influenza Hospitalizations and Deaths (PCIRN)

    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network concluded for the 2012-13 influenza season on April 30th, 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance, and active surveillance will start again on November 15th, 2013. No hospitalizations, ICU admissions or deaths were reported in week 42.
    To date this season, three influenza-associated adult hospitalizations have been reported by the PCIRN-SOS network, all with influenza A(unsubtyped). Two were 45-64 years of age, and one ≥65 years of age. ICU admission was required for one hospitalization and no deaths have been reported.

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Provincial/Territorial Influenza Hospitalizations and Deaths (Aggregate Surveillance System<SUP>*</SUP>)
    In week 42, one new laboratory-confirmed influenza-associated hospitalization was reported from participating provinces and territories.<SUP>*</SUP> The case was reported in a child 0-4 years of age with influenza A(unsubtyped). No ICU admissions or deaths were reported.

    To date this season, seven influenza-associated hospitalizations have been reported. One case was reported in an adult ≥65 years of age, three cases were reported in adults 45-64 years of age, and three cases in children 0-4 years of age. Five (71%) cases had influenza A [one A(H3), two A(H1), and two A(unsubtyped)], and two (29%) had influenza B. One ICU admission was reported in an adult 45-64 years of age and no deaths have been reported.

    * Note: The number of new influenza-associated hospitalizations and deaths reported by the Aggregate Surveillance System each week may be overestimated, as it may include retrospective updates to data from Ontario for previous weeks. These data may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Week 41

    FluWatch report: October 6 to 12, 2013 (Week 41)

    Posted 2013-10-18For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w41_13/pdf/fw2013-41-eng.pdf">FluWatch report: October 6 to 12, 2013 (Week 41) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 113 <ABBR title=Kilobytes>KB</ABBR> - 8 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada remained at inter-seasonal levels in week 41.
    • Few laboratory detections of influenza have been reported to date this season; rhinovirus and parainfluenza were the predominant respiratory viruses in circulation in week 41.
    • The ILI consultation rate has followed a gradual upward trend over the past four weeks.
    Influenza Activity (geographic spread) and Outbreaks

    In week 41, four regions (in BC, AB(2) and ON) reported sporadic activity (Figure 1). Localized activity has not been reported since week 26 of the 2012-13 season (Figure 2). No new influenza outbreaks were reported in week 41 (Figure 3).
    Figure 1. Map of overall Influenza activity level by province and territory, Canada, Week 41





    Note: Influenza activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates (see graphs and tables) and reported outbreaks. Please refer to detailed definitions on the last page. For areas where no data is reported, late reports from these provinces and territories will appear on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Figure 2. Number of influenza surveillance regions<SUP title="sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in">?</SUP> reporting widespread or localized influenza activity, Canada, by report week, 2013-2014 (N<SUP>*</SUP>=58)


    ?sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.
    * Total number of influenza surveillance regions in Canada
    Text equivalent for figure 2Number of influenza surveillance regions reporting widespread or localized influenza activity, Canada, by report week, 2011-2012 (N=56)
    Figure 3. Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014


    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2011-2012

    Top of Page

    Influenza and Other Respiratory Virus Detections

    The overall percentage of positive influenza tests was low and stable, at 0.4% in week 41. Among the seven influenza viruses detected in week 41, five were influenza A (Table 1). Cumulative influenza virus detections by type/subtype to date are as follows: 75.8% influenza A [16% A(H3), 40% A(H1N1)pdm09 and 44% A(unsubtyped)] and 24.2% influenza B (Table 1).
    Detailed information on age and type/subtype has been received for 27 cases to date this season (Table 2). The proportion of cases by age group is as follows: 18.5% <5 years; 0% between 5-19 years; 18.5% between 20-44 years; 48.1% between 45-64 years; and 14.8% ≥65 years of age.
    The percentage of positive tests for rhinovirus decreased slightly from 33.6% in week 40 to 31.9% in week 41. The percentage of positive tests for parainfluenza was stable at 4.1% in week 41. The percentages of positive tests for other respiratory viruses were low in week 41: human metapneumovirus (hMPV) (0.3%), respiratory syncytial virus (RSV) (0.8%), coronavirus (0.3%) and adenovirus (1.7%) (Figure 5)<SUP>*</SUP>.
    * For more details, see the weekly Respiratory Virus Detections in Canada Report.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly & Cumulative numbers of positive influenza specimens
    by Provincial Laboratories, Canada, 2013-2014
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces</TH><TH id=ac1 colSpan=6>Weekly
    (October 6 to 12, 2013)
    </TH><TH id=ac9 colSpan=6>Cumulative
    (August 25, 2013 to October 12, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=5 headers=ac1>Influenza A</TH><TH id=ac8 headers=ac1>Influenza
    B
    </TH><TH id=ac10 colSpan=5 headers=ac9>Influenza A</TH><TH id=ac16 headers=ac9>Influenza
    B
    </TH></TR><TR class=bg-colour-yellow><TH id=ac3 headers=ac2>A Total</TH><TH id=ac4 headers=ac2>A(H1)</TH><TH id=ac5 headers=ac2>A(H3)</TH><TH id=ac6 headers=ac2>Pand H1N1</TH><TH id=ac7 class=noWrap headers=ac2>A
    ( <ABBR title=unsubtyped>Un S</ABBR>)Table 1 note*
    </TH><TH headers="ac1 ac8">Total</TH><TH id=ac11 headers=ac10>A Total</TH><TH id=ac12 headers=ac10>A(H1)</TH><TH id=ac13 headers=ac10>A(H3)</TH><TH id=ac14 headers=ac10>Pand H1N1</TH><TH id=ac15 class=noWrap headers=ac10>A
    (Un S) Table 1 note*
    </TH><TH headers=ac16>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13>* Unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available. Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Note: Weekly data is based on week of positive lab detection. Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals. </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=bg-colour-yellow headers=ar1><ABBR title="British Columbia ">BC</ABBR></TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac8">1 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac16">3 </TD></TR><TR><TH id=ar3 class=bg-colour-yellow headers=ar1><ABBR title=Alberta>AB</ABBR></TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">2 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac11">8 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac13">1 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac14">6 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac15">1 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac16">2 </TD></TR><TR><TH id=ar4 class=bg-colour-yellow headers=ar1><ABBR title=Saskatchewan>SK</ABBR></TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac11">2 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac15">2 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac16">0 </TD></TR><TR><TH id=ar5 class=bg-colour-yellow headers=ar1><ABBR title=Manitoba>MB</ABBR></TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac16">0 </TD></TR><TR><TH id=ar6 class=bg-colour-yellow headers=ar1><ABBR title=Ontario>ON</ABBR></TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">3 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac8">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac11">8 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac13">3 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac14">3 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac15">2 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac16">3 </TD></TR><TR><TH id=ar7 class=bg-colour-yellow headers=ar1><ABBR title=Quebec>QC</ABBR></TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac11">6 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac15">6 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac16">0 </TD></TR><TR><TH id=ar8 class=bg-colour-yellow headers=ar1><ABBR title="New Brunswick">NB</ABBR></TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac11">1 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac14">1 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac16">0 </TD></TR><TR><TH id=ar9 class=bg-colour-yellow headers=ar1><ABBR title="Nova Scotia ">NS</ABBR></TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac16">0 </TD></TR><TR><TH id=ar10 class=bg-colour-yellow headers=ar1><ABBR title="Prince Edward Island ">PE</ABBR></TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac16">0 </TD></TR><TR><TH id=ar11 class=bg-colour-yellow headers=ar1><ABBR title="Newfoundland/Labrador ">NL</ABBR></TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac16">0 </TD></TR><TR><TH id=ar12 class=bg-colour-yellow headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">5 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac5">2 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac7">2 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac8">2 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac11">25 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac13">4 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac14">10 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac15">11 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac16">8 </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 2. Weekly & Cumulative numbers of positive influenza specimens by age groups
    reported through case-based laboratory reporting, Canada, 2013-2014 Table 2 note*
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups</TH><TH id=bc1 colSpan=5>Weekly
    (October 6 to 12, 2013)
    </TH><TH id=bc8 colSpan=5>Cumulative
    (August 25, 2013 to October 12, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH></TR><TR class=bg-colour-yellow><TH id=bc3 headers=bc2>A Total</TH><TH id=bc4 headers=bc2>Pandemic H1N1</TH><TH id=bc5 headers=bc2>A/H3N2</TH><TH id=bc6 headers=bc2>A unsubtyped</TH><TH headers="bc1 bc7">Total</TH><TH id=bc10 headers=bc9>A Total</TH><TH id=bc11 headers=bc9>Pandemic H1N1</TH><TH id=bc12 headers=bc9>A/H3N2</TH><TH id=bc13 headers=bc9>A unsubtyped</TH><TH headers=bc14>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11>* Please note that this table reflects the number of specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported. Delays in the reporting of data may cause data to change retrospectively.</TD></TR></TFOOT><TBODY><TR><TH id=br2 headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">5 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">2 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">3 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">0 </TD></TR><TR><TH id=br3 headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">0 </TD></TR><TR><TH id=br4 headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">1 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">4 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">1 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">2 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">1 </TD></TR><TR><TH id=br5 headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">1 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">10 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">8 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">2 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">3 </TD></TR><TR><TH id=br6 headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">2 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">2 </TD></TR><TR><TH id=br7 headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">0 </TD></TR><TR><TH id=br8 headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">3 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc4">1 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc5">1 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">21 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc11">9 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc12">4 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc13">8 </TD><TD class=alignCenter headers="br1 br8 bc8 bc14">6 </TD></TR></TBODY></TABLE>


    Top of Page

    Figure 4. Influenza tests reported and percentage of tests positive,
    by report week, Canada, 2013-2014


    Text equivalent for figure 4Influenza tests reported and percentage of tests positive, Canada, by report week, 2011-2012
    Figure 5. Percent positive influenza tests, compared to other respiratory viruses,
    by reporting week, Canada, 2013-2014


    Text equivalent for figure 5Percent positive influenza tests, compared to other respiratory viruses, Canada, by reporting week, 2011-2012

    Top of Page

    Influenza Strain Characterizations

    The National Microbiology Laboratory (NML) has not yet conducted antigenic characterization of influenza viruses in the 2013-14 season.
    Figure 6. Influenza strain characterizations, Canada, 2013-2014, N =0

    Note: The WHO recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus.
    Text equivalent for figure 6Influenza strain characterizations, Canada, 2011-2012

    Top of Page

    Antiviral Resistance

    The NML has not yet conducted antiviral resistance testing of influenza viruses in the 2013-14 season.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">0</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">0</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">0</TD><TD class=alignCenter headers="cr2 cc9">0</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">0</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">0</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">0</TD><TD class=alignCenter headers="cr3 cc9">0</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">0</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">0</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">0</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">0</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">0</TD><TD class=alignCenter headers="cr5 cc9">0</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate decreased from 30.4/1,000 visits in week 40 to 24.3/1,000 in week 41, while maintaining a general upward trend in recent weeks (Figure 7).
    Figure 7. Influenza-like illness (ILI) consultation rates, by report week, Canada, 2013-2014 compared to 1996/97 through to 2011/12 seasons (with pandemic data suppressed)

    Note: No data available for mean rate in previous years for weeks 19 to 39 (1996-1997 through 2002-2003 seasons). Delays in the reporting of data may cause data to change retrospectively.
    Text equivalent for figure 7Influenza-like illness (ILI) consultation rates, Canada, by report week, 2011-2012 compared to 1996/97 through to 2010/11 seasons (with pandemic data suppressed)

    Top of Page


    Severe Respiratory Illness Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)

    No laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations have been reported in any of the 12 hospitals participating in the Immunization Monitoring Program Active (IMPACT) network in week 41.

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Adult Influenza Hospitalizations and Deaths (PCIRN)

    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network concluded for the 2012-13 influenza season on April 30th, 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance, and active surveillance will start again on November 15th, 2013. One new hospitalization and ICU admission was reported in week 41 in an adult 45-64 years of age with influenza A. No deaths were reported.

    From week 35 to week 41, three influenza-associated adult hospitalizations have been reported by the PCIRN-SOS network, all with influenza A(unsubtyped). Two were 45-64 years of age, and one ≥65 years of age. ICU admission was required for one hospitalization and no deaths have been reported.

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Provincial/Territorial Influenza Hospitalizations and Deaths (Aggregate Surveillance System<SUP>*</SUP>)

    In week 41, one new laboratory-confirmed influenza-associated hospitalization was reported from participating provinces and territories (five of eight reporting in week 41).<SUP>*</SUP> The case was reported in an adult 45-64 years of age with influenza B. No ICU admissions or deaths were reported.

    To date this season, four influenza-associated hospitalizations have been reported. Three cases were reported in adults 45-64 years of age, and one was reported in a child 0-4 years; 3 (75%) had influenza A [of which 1 was A(H3) and 2 was A(H1)], and 1 (25%) had influenza B. One ICU admission was reported in an adult among the four cases and no deaths were reported.

    * Note: The number of new influenza-associated hospitalizations and deaths reported by the Aggregate Surveillance System each week may be overestimated, as it may include retrospective updates to data from Ontario for previous weeks. These data may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Weeks 39 &amp; 40

    FluWatch report: September 22 to October 5, 2013 (Weeks 39 & 40)

    Posted 2013-10-11For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w40_13/pdf/fw2013-40-eng.pdf">FluWatch report: September 22 to October 5, 2013 (Weeks 39 & 40) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 113 <ABBR title=Kilobytes>KB</ABBR> - 8 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada remained at inter-seasonal levels during this 2-week period.
    • Few laboratory detections of influenza have been reported to date this season; detections of rhinovirus and parainfluenza increased during this 2-week period.
    • The ILI consultation rate increased over the past three weeks.
    Influenza Activity (geographic spread) and Outbreaks

    The number of regions reporting influenza activity was at inter-seasonal levels in weeks 39 and 40. During this period, six regions reported sporadic activity (Figure 1). ). Localized activity has not been reported since week 26 of the 2012-13 season (Figure 2).No new influenza outbreaks were reported in weeks 39 or 40 (Figure 3).
    Figure 1. Map of overall Influenza activity level by province and territory,
    Canada, Week 40





    Note: Influenza activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates (see graphs and tables) and reported outbreaks. Please refer to detailed definitions on the last page. For areas where no data is reported, late reports from these provinces and territories will appear on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Figure 2. Number of influenza surveillance regions<SUP title="sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in">?</SUP> reporting widespread or localized influenza activity, Canada, by report week, 2013-2014 (N<SUP>*</SUP>=58)


    ?sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.
    * Total number of influenza surveillance regions in Canada
    Text equivalent for figure 2Number of influenza surveillance regions reporting widespread or localized influenza activity, Canada, by report week, 2011-2012 (N=56)
    Figure 3. Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014


    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2011-2012

    Top of Page

    Influenza and Other Respiratory Virus Detections

    The overall percentage of positive influenza tests was low and stable, at 0.2% in week 39 and 0.3% in week 40. Among the nine influenza viruses detected in weeks 39 and 40, seven were influenza A (Table 1). Cumulative influenza virus detections by type/subtype to date are as follows: 76.9% influenza A [10% A(H3), 45% A(H1N1)pdm09 and 45% A(unsubtyped)] and 23.1% influenza B (Table 1).
    Detailed information on age and type/subtype has been received for 22 cases to date this season (Table 2). The proportion of cases by age group is as follows: 18.2% <5 years; 0% between 5-19 years; 18.2% between 20-44 years; 54.5% between 45-64 years; and 9.1% ≥65 years of age.
    The percentage of positive tests for rhinovirus increased slightly from 31.3% in week 38 to 31.8% in week 39, then decreased to 28.8% in week 40. The percentage of positive tests for parainfluenza increased from 2.9% in week 38 to 4.1% in week 40. The percentages of positive tests for other respiratory viruses were low in week 40: human metapneumovirus (hMPV) (0.4%), respiratory syncytial virus (RSV) (0.4%), coronavirus (0.4%) and adenovirus (1.2%) (Figure 5)<SUP>*</SUP>.
    * For more details, see the weekly Respiratory Virus Detections in Canada Report.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly & Cumulative numbers of positive influenza specimens
    by Provincial Laboratories, Canada, 2013-2014
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces</TH><TH id=ac1 colSpan=6>Weekly
    (September 22 to October 5, 2013)
    </TH><TH id=ac9 colSpan=6>Cumulative
    (August 25, 2013 to October 5, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=5 headers=ac1>Influenza A</TH><TH id=ac8 headers=ac1>Influenza
    B
    </TH><TH id=ac10 colSpan=5 headers=ac9>Influenza A</TH><TH id=ac16 headers=ac9>Influenza
    B
    </TH></TR><TR class=bg-colour-yellow><TH id=ac3 headers=ac2>A Total</TH><TH id=ac4 headers=ac2>A(H1)</TH><TH id=ac5 headers=ac2>A(H3)</TH><TH id=ac6 headers=ac2>Pand H1N1</TH><TH id=ac7 class=noWrap headers=ac2>A
    ( <ABBR title=unsubtyped>Un S</ABBR>)Table 1 note*
    </TH><TH headers="ac1 ac8">Total</TH><TH id=ac11 headers=ac10>A Total</TH><TH id=ac12 headers=ac10>A(H1)</TH><TH id=ac13 headers=ac10>A(H3)</TH><TH id=ac14 headers=ac10>Pand H1N1</TH><TH id=ac15 class=noWrap headers=ac10>A
    (Un S) Table 1 note*
    </TH><TH headers=ac16>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13>* Unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available. Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Note: Weekly data is based on week of positive lab detection. Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals. </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=bg-colour-yellow headers=ar1><ABBR title="British Columbia ">BC</ABBR></TH><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar2 ac1 ac8">1</TD><TD class=alignRight headers="ar1 ar2 ac9 ac10 ac11">0</TD><TD class=alignRight headers="ar1 ar2 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar2 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar2 ac9 ac10 ac14">0</TD><TD class=alignRight headers="ar1 ar2 ac9 ac10 ac15">0</TD><TD class=alignRight headers="ar1 ar2 ac9 ac16">2</TD></TR><TR><TH id=ar3 class=bg-colour-yellow headers=ar1><ABBR title=Alberta>AB</ABBR></TH><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac3">1</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac6">1</TD><TD class=alignRight headers="ar1 ar3 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar3 ac1 ac8">1</TD><TD class=alignRight headers="ar1 ar3 ac9 ac10 ac11">6</TD><TD class=alignRight headers="ar1 ar3 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar3 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar3 ac9 ac10 ac14">6</TD><TD class=alignRight headers="ar1 ar3 ac9 ac10 ac15">0</TD><TD class=alignRight headers="ar1 ar3 ac9 ac16">2</TD></TR><TR><TH id=ar4 class=bg-colour-yellow headers=ar1><ABBR title=Saskatchewan>SK</ABBR></TH><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar4 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar4 ac9 ac10 ac11">2</TD><TD class=alignRight headers="ar1 ar4 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar4 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar4 ac9 ac10 ac14">0</TD><TD class=alignRight headers="ar1 ar4 ac9 ac10 ac15">2</TD><TD class=alignRight headers="ar1 ar4 ac9 ac16">0</TD></TR><TR><TH id=ar5 class=bg-colour-yellow headers=ar1><ABBR title=Manitoba>MB</ABBR></TH><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar5 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar5 ac9 ac10 ac11">0</TD><TD class=alignRight headers="ar1 ar5 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar5 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar5 ac9 ac10 ac14">0</TD><TD class=alignRight headers="ar1 ar5 ac9 ac10 ac15">0</TD><TD class=alignRight headers="ar1 ar5 ac9 ac16">0</TD></TR><TR><TH id=ar6 class=bg-colour-yellow headers=ar1><ABBR title=Ontario>ON</ABBR></TH><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac3">2</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac6">1</TD><TD class=alignRight headers="ar1 ar6 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar6 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar6 ac9 ac10 ac11">5</TD><TD class=alignRight headers="ar1 ar6 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar6 ac9 ac10 ac13">2</TD><TD class=alignRight headers="ar1 ar6 ac9 ac10 ac14">2</TD><TD class=alignRight headers="ar1 ar6 ac9 ac10 ac15">1</TD><TD class=alignRight headers="ar1 ar6 ac9 ac16">2</TD></TR><TR><TH id=ar7 class=bg-colour-yellow headers=ar1><ABBR title=Quebec>QC</ABBR></TH><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac3">3</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar7 ac1 ac2 ac7">3</TD><TD class=alignRight headers="ar1 ar7 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar7 ac9 ac10 ac11">6</TD><TD class=alignRight headers="ar1 ar7 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar7 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar7 ac9 ac10 ac14">0</TD><TD class=alignRight headers="ar1 ar7 ac9 ac10 ac15">6</TD><TD class=alignRight headers="ar1 ar7 ac9 ac16">0</TD></TR><TR><TH id=ar8 class=bg-colour-yellow headers=ar1><ABBR title="New Brunswick">NB</ABBR></TH><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac3">1</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac6">1</TD><TD class=alignRight headers="ar1 ar8 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar8 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar8 ac9 ac10 ac11">1</TD><TD class=alignRight headers="ar1 ar8 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar8 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar8 ac9 ac10 ac14">1</TD><TD class=alignRight headers="ar1 ar8 ac9 ac10 ac15">0</TD><TD class=alignRight headers="ar1 ar8 ac9 ac16">0</TD></TR><TR><TH id=ar9 class=bg-colour-yellow headers=ar1><ABBR title="Nova Scotia ">NS</ABBR></TH><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar9 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar9 ac9 ac10 ac11">0</TD><TD class=alignRight headers="ar1 ar9 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar9 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar9 ac9 ac10 ac14">0</TD><TD class=alignRight headers="ar1 ar9 ac9 ac10 ac15">0</TD><TD class=alignRight headers="ar1 ar9 ac9 ac16">0</TD></TR><TR><TH id=ar10 class=bg-colour-yellow headers=ar1><ABBR title="Prince Edward Island ">PE</ABBR></TH><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar10 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar10 ac9 ac10 ac11">0</TD><TD class=alignRight headers="ar1 ar10 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar10 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar10 ac9 ac10 ac14">0</TD><TD class=alignRight headers="ar1 ar10 ac9 ac10 ac15">0</TD><TD class=alignRight headers="ar1 ar10 ac9 ac16">0</TD></TR><TR><TH id=ar11 class=bg-colour-yellow headers=ar1><ABBR title="Newfoundland/Labrador ">NL</ABBR></TH><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac3">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac5">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac6">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac2 ac7">0</TD><TD class=alignRight headers="ar1 ar11 ac1 ac8">0</TD><TD class=alignRight headers="ar1 ar11 ac9 ac10 ac11">0</TD><TD class=alignRight headers="ar1 ar11 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar11 ac9 ac10 ac13">0</TD><TD class=alignRight headers="ar1 ar11 ac9 ac10 ac14">0</TD><TD class=alignRight headers="ar1 ar11 ac9 ac10 ac15">0</TD><TD class=alignRight headers="ar1 ar11 ac9 ac16">0</TD></TR><TR><TH id=ar12 class=bg-colour-yellow headers=ar1>Canada</TH><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac3">7</TD><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac4">0</TD><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac5">1</TD><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac6">3</TD><TD class=alignRight headers="ar1 ar12 ac1 ac2 ac7">3</TD><TD class=alignRight headers="ar1 ar12 ac1 ac8">2</TD><TD class=alignRight headers="ar1 ar12 ac9 ac10 ac11">20</TD><TD class=alignRight headers="ar1 ar12 ac9 ac10 ac12">0</TD><TD class=alignRight headers="ar1 ar12 ac9 ac10 ac13">2</TD><TD class=alignRight headers="ar1 ar12 ac9 ac10 ac14">9</TD><TD class=alignRight headers="ar1 ar12 ac9 ac10 ac15">9</TD><TD class=alignRight headers="ar1 ar12 ac9 ac16">6</TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 2. Weekly & Cumulative numbers of positive influenza specimens by age groups
    reported through case-based laboratory reporting, Canada, 2013-2014 Table 2 note*
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups</TH><TH id=bc1 colSpan=5>Weekly
    (September 22 to October 5, 2013)
    </TH><TH id=bc8 colSpan=5>Cumulative
    (August 25, 2013 to October 5, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH></TR><TR class=bg-colour-yellow><TH id=bc3 headers=bc2>A Total</TH><TH id=bc4 headers=bc2>Pandemic H1N1</TH><TH id=bc5 headers=bc2>A/H3N2</TH><TH id=bc6 headers=bc2>A unsubtyped</TH><TH headers="bc1 bc7">Total</TH><TH id=bc10 headers=bc9>A Total</TH><TH id=bc11 headers=bc9>Pandemic H1N1</TH><TH id=bc12 headers=bc9>A/H3N2</TH><TH id=bc13 headers=bc9>A unsubtyped</TH><TH headers=bc14>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11>* Please note that this table reflects the number of specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported. Delays in the reporting of data may cause data to change retrospectively.</TD></TR></TFOOT><TBODY><TR><TH id=br2 headers=br1><5</TH><TD class=alignRight headers="br1 br2 bc1 bc2 bc3">0</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br2 bc1 bc2 bc6">0</TD><TD class=alignRight headers="br1 br2 bc1 bc7">0</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc10">4</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc11">0</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc12">2</TD><TD class=alignRight headers="br1 br2 bc8 bc9 bc13">2</TD><TD class=alignRight headers="br1 br2 bc8 bc14">0</TD></TR><TR><TH id=br3 headers=br1>5-19</TH><TD class=alignRight headers="br1 br3 bc1 bc2 bc3">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br3 bc1 bc2 bc6">0</TD><TD class=alignRight headers="br1 br3 bc1 bc7">0</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc10">0</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc11">0</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc12">0</TD><TD class=alignRight headers="br1 br3 bc8 bc9 bc13">0</TD><TD class=alignRight headers="br1 br3 bc8 bc14">0</TD></TR><TR><TH id=br4 headers=br1>20-44</TH><TD class=alignRight headers="br1 br4 bc1 bc2 bc3">2</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc4">1</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br4 bc1 bc2 bc6">1</TD><TD class=alignRight headers="br1 br4 bc1 bc7">0</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc10">3</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc11">1</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc12">0</TD><TD class=alignRight headers="br1 br4 bc8 bc9 bc13">2</TD><TD class=alignRight headers="br1 br4 bc8 bc14">1</TD></TR><TR><TH id=br5 headers=br1>45-64</TH><TD class=alignRight headers="br1 br5 bc1 bc2 bc3">3</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc4">1</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br5 bc1 bc2 bc6">2</TD><TD class=alignRight headers="br1 br5 bc1 bc7">2</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc10">9</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc11">7</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc12">0</TD><TD class=alignRight headers="br1 br5 bc8 bc9 bc13">2</TD><TD class=alignRight headers="br1 br5 bc8 bc14">3</TD></TR><TR><TH id=br6 headers=br1>65+</TH><TD class=alignRight headers="br1 br6 bc1 bc2 bc3">0</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br6 bc1 bc2 bc6">0</TD><TD class=alignRight headers="br1 br6 bc1 bc7">0</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc10">1</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc11">0</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc12">0</TD><TD class=alignRight headers="br1 br6 bc8 bc9 bc13">1</TD><TD class=alignRight headers="br1 br6 bc8 bc14">1</TD></TR><TR><TH id=br7 headers=br1>Unknown</TH><TD class=alignRight headers="br1 br7 bc1 bc2 bc3">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc4">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br7 bc1 bc2 bc6">0</TD><TD class=alignRight headers="br1 br7 bc1 bc7">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc10">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc11">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc12">0</TD><TD class=alignRight headers="br1 br7 bc8 bc9 bc13">0</TD><TD class=alignRight headers="br1 br7 bc8 bc14">0</TD></TR><TR><TH id=br8 headers=br1>Total</TH><TD class=alignRight headers="br1 br8 bc1 bc2 bc3">5</TD><TD class=alignRight headers="br1 br8 bc1 bc2 bc4">2</TD><TD class=alignRight headers="br1 br8 bc1 bc2 bc5">0</TD><TD class=alignRight headers="br1 br8 bc1 bc2 bc6">3</TD><TD class=alignRight headers="br1 br8 bc1 bc7">2</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc10">17</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc11">8</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc12">2</TD><TD class=alignRight headers="br1 br8 bc8 bc9 bc13">7</TD><TD class=alignRight headers="br1 br8 bc8 bc14">5</TD></TR></TBODY></TABLE>


    Top of Page

    Figure 4. Influenza tests reported and percentage of tests positive,
    by report week, Canada, 2013-2014


    Text equivalent for figure 4Influenza tests reported and percentage of tests positive, Canada, by report week, 2011-2012
    Figure 5. Percent positive influenza tests, compared to other respiratory viruses,
    by reporting week, Canada, 2013-2014


    Text equivalent for figure 5Percent positive influenza tests, compared to other respiratory viruses, Canada, by reporting week, 2011-2012

    Top of Page

    Influenza Strain Characterizations

    The National Microbiology Laboratory (NML) has not yet conducted antigenic characterization of influenza viruses in the 2013-14 season.
    Figure 6. Influenza strain characterizations, Canada, 2013-2014, N =0

    Note: The WHO recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus.
    Text equivalent for figure 6Influenza strain characterizations, Canada, 2011-2012

    Top of Page

    Antiviral Resistance

    The NML has not yet conducted antiviral resistance testing of influenza viruses in the 2013-14 season.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">0</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">0</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">0</TD><TD class=alignCenter headers="cr2 cc9">0</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">0</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">0</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">0</TD><TD class=alignCenter headers="cr3 cc9">0</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">0</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">0</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">0</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">0</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">0</TD><TD class=alignCenter headers="cr5 cc9">0</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate increased from 20.6/1,000 visits in week 38 to 24.9/1,000 in week 39 and 26.9/1,000 in week 40 (Figure 7).
    Figure 7. Influenza-like illness (ILI) consultation rates, by report week, Canada, 2013-2014 compared to 1996/97 through to 2011/12 seasons (with pandemic data suppressed)

    Note: No data available for mean rate in previous years for weeks 19 to 39 (1996-1997 through 2002-2003 seasons). Delays in the reporting of data may cause data to change retrospectively.
    Text equivalent for figure 7Influenza-like illness (ILI) consultation rates, Canada, by report week, 2011-2012 compared to 1996/97 through to 2010/11 seasons (with pandemic data suppressed)

    Top of Page


    Severe Respiratory Illness Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)

    No laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations have been reported in any of the 12 hospitals participating in the Immunization Monitoring Program Active (IMPACT) network in weeks 39 or 40.

    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network concluded for the 2012-13 influenza season on April 30th, 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance, and active surveillance will start again on November 15th, 2013. Two new hospitalizations were reported in weeks 39 and 40, both adults with influenza A, one 45-64 years of age and one ≥65 years of age. No ICU admissions or deaths were reported.

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Provincial/Territorial Influenza Hospitalizations and Deaths (Aggregate Surveillance System<SUP>*</SUP>)

    In weeks 39 and 40, one new laboratory-confirmed influenza-associated hospitalization was reported from participating provinces and territories<SUP>*</SUP>. The case was a child 0-4 years of age with influenza A(H3N2). To date this season, three influenza-associated hospitalizations have been reported. The two previous cases were adults 45-64 years of age with influenza A(H1N1)pdm09. One ICU admission was reported among the three cases and no deaths were reported.

    * Note: The number of new influenza-associated hospitalizations and deaths reported by the Aggregate Surveillance System each week may be overestimated, as it may include retrospective updates to data from Ontario for previous weeks. These data may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.

    .../

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Weeks 35 &amp; 36

    FluWatch report: September 8 to September 21, 2013 (Weeks 37 & 38)

    Posted 2013-09-30For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w38_13/pdf/fw2013-38-eng.pdf">FluWatch report: September 8 to September 21, 2013 (Weeks 37 & 38) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 113 <ABBR title=Kilobytes>KB</ABBR> - 8 pages)

    ?? Help with PDF documents


    Overall Summary
    • Influenza activity in Canada remained at inter-seasonal levels during this 2-week period.
    • The number of laboratory tests positive for all respiratory viruses was similar to previous weeks.
    • The ILI consultation rate was stable in recent weeks, with a slight increase seen in week 38.
    NOTE: Fortnightly reports will continue until October 11, 2013. Laboratory detections reported through the Respiratory Virus Detection Surveillance System and influenza activity level maps continue to be updated weekly on the FluWatch website.

    Influenza Activity (geographic spread) and Outbreaks

    The number of regions reporting influenza activity was at inter-seasonal levels in weeks 37 and 38. During this period, four regions reported sporadic activity (Figure 1). Localized activity has not been reported since week 26 of the 2012-13 season (Figure 2). No new influenza outbreaks were reported in weeks 37 or 38 (Figure 3).
    Figure 1. Map of overall Influenza activity level by province and territory,
    Canada, Week 38





    Note: Influenza activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates (see graphs and tables) and reported outbreaks. Please refer to detailed definitions on the last page. For areas where no data is reported, late reports from these provinces and territories will appear on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Figure 2. Number of influenza surveillance regions<SUP title="sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in">?</SUP> reporting widespread or localized influenza activity, Canada, by report week, 2013-2014 (N<SUP>*</SUP>=58)


    ?sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.
    * Total number of influenza surveillance regions in Canada
    Text equivalent for figure 2Number of influenza surveillance regions reporting widespread or localized influenza activity, Canada, by report week, 2011-2012 (N=56)
    Figure 3. Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014


    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2011-2012

    Top of Page

    Influenza and Other Respiratory Virus Detections

    The overall percentage of positive influenza tests was low and stable, at 0.3% in week 37 and 0.2% in week 38. Among the seven influenza viruses detected in weeks 37 and 38, five were influenza A (Table 1). Cumulative influenza virus detections by type/subtype to date are as follows: 76.5% influenza A [7.7% A(H3), 46.2% A(H1N1)pdm09 and 45.2% A(unsubtyped)] and 23.5% influenza B (Table 1).
    Detailed information on age and type/subtype has been received for 14 cases to date this season (Table 2). The proportion of cases by age group is as follows: 21.4% <5 years; 0% between 5-19 years; 7.1% between 20-44 years; 57.1% between 45-64 years; and 14.3% ≥65 years of age.
    The percentage of positive tests for rhinovirus increased during this 2-week period from 23.1% in week 36 to 30.3% in week 38; the number of positive tests also increased compared to previous weeks. The percentages of positive tests for other respiratory viruses were low in week 38: parainfluenza (2.9%), human metapneumovirus (hMPV) (0.1%), respiratory syncytial virus (RSV) (0.4%), coronavirus (0.1%) and adenovirus (1.3%) (Figure 5)<SUP>*</SUP>.
    * For more details, see the weekly Respiratory Virus Detections in Canada Report.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly & Cumulative numbers of positive influenza specimens
    by Provincial Laboratories, Canada, 2013-2014
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces</TH><TH id=ac1 colSpan=6>Weekly
    (September 8 to September 21, 2013)
    </TH><TH id=ac9 colSpan=6>Cumulative
    (August 25, 2013 to September 21, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=5 headers=ac1>Influenza A</TH><TH id=ac8 headers=ac1>Influenza
    B
    </TH><TH id=ac10 colSpan=5 headers=ac9>Influenza A</TH><TH id=ac16 headers=ac9>Influenza
    B
    </TH></TR><TR class=bg-colour-yellow><TH id=ac3 headers=ac2>A Total</TH><TH id=ac4 headers=ac2>A(H1)</TH><TH id=ac5 headers=ac2>A(H3)</TH><TH id=ac6 headers=ac2>Pand H1N1</TH><TH id=ac7 class=noWrap headers=ac2>A
    ( <ABBR title=unsubtyped>Un S</ABBR>)Table 1 note*
    </TH><TH headers="ac1 ac8">Total</TH><TH id=ac11 headers=ac10>A Total</TH><TH id=ac12 headers=ac10>A(H1)</TH><TH id=ac13 headers=ac10>A(H3)</TH><TH id=ac14 headers=ac10>Pand H1N1</TH><TH id=ac15 class=noWrap headers=ac10>A
    (Un S) Table 1 note*
    </TH><TH headers=ac16>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13>* Unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available. Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Note: Weekly data is based on week of positive lab detection. Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals. </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=bg-colour-yellow headers=ar1><ABBR title="British Columbia ">BC</ABBR></TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac16">1 </TD></TR><TR><TH id=ar3 class=bg-colour-yellow headers=ar1><ABBR title=Alberta>AB</ABBR></TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac8">1 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac11">5 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac14">5 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac16">1 </TD></TR><TR><TH id=ar4 class=bg-colour-yellow headers=ar1><ABBR title=Saskatchewan>SK</ABBR></TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac11">2 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac15">2 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac16">0 </TD></TR><TR><TH id=ar5 class=bg-colour-yellow headers=ar1><ABBR title=Manitoba>MB</ABBR></TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac16">0 </TD></TR><TR><TH id=ar6 class=bg-colour-yellow headers=ar1><ABBR title=Ontario>ON</ABBR></TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac8">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac11">3 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac13">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac14">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac15">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac16">2 </TD></TR><TR><TH id=ar7 class=bg-colour-yellow headers=ar1><ABBR title=Quebec>QC</ABBR></TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">3 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac7">3 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac11">3 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac15">3 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac16">0 </TD></TR><TR><TH id=ar8 class=bg-colour-yellow headers=ar1><ABBR title="New Brunswick">NB</ABBR></TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac16">0 </TD></TR><TR><TH id=ar9 class=bg-colour-yellow headers=ar1><ABBR title="Nova Scotia ">NS</ABBR></TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac16">0 </TD></TR><TR><TH id=ar10 class=bg-colour-yellow headers=ar1><ABBR title="Prince Edward Island ">PE</ABBR></TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac16">0 </TD></TR><TR><TH id=ar11 class=bg-colour-yellow headers=ar1><ABBR title="Newfoundland/Labrador ">NL</ABBR></TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac16">0 </TD></TR><TR><TH id=ar12 class=bg-colour-yellow headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">5 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac7">4 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac8">2 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac11">13 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac13">1 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac14">6 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac15">6 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac16">4 </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 2. Weekly & Cumulative numbers of positive influenza specimens by age groups
    reported through case-based laboratory reporting, Canada, 2013-2014 Table 2 note*
    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups</TH><TH id=bc1 colSpan=5>Weekly
    (September 8 to September 21, 2013)
    </TH><TH id=bc8 colSpan=5>Cumulative
    (August 25, 2013 to September 21, 2013)
    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH></TR><TR class=bg-colour-yellow><TH id=bc3 headers=bc2>A Total</TH><TH id=bc4 headers=bc2>Pandemic H1N1</TH><TH id=bc5 headers=bc2>A/H3N2</TH><TH id=bc6 headers=bc2>A unsubtyped</TH><TH headers="bc1 bc7">Total</TH><TH id=bc10 headers=bc9>A Total</TH><TH id=bc11 headers=bc9>Pandemic H1N1</TH><TH id=bc12 headers=bc9>A/H3N2</TH><TH id=bc13 headers=bc9>A unsubtyped</TH><TH headers=bc14>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11>* Please note that this table reflects the number of specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported. Delays in the reporting of data may cause data to change retrospectively.</TD></TR></TFOOT><TBODY><TR><TH id=br2 headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">3 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">2 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">0 </TD></TR><TR><TH id=br3 headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">0 </TD></TR><TR><TH id=br4 headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">1 </TD></TR><TR><TH id=br5 headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">2 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">1 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">7 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">6 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">1 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">1 </TD></TR><TR><TH id=br6 headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">1 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">1 </TD></TR><TR><TH id=br7 headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">0 </TD></TR><TR><TH id=br8 headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">4 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc4">1 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc6">3 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">2 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">11 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc11">6 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc13">4 </TD><TD class=alignCenter headers="br1 br8 bc8 bc14">3 </TD></TR></TBODY></TABLE>


    Top of Page

    Figure 4. Influenza tests reported and percentage of tests positive,
    by report week, Canada, 2013-2014


    Text equivalent for figure 4Influenza tests reported and percentage of tests positive, Canada, by report week, 2011-2012
    Figure 5. Percent positive influenza tests, compared to other respiratory viruses,
    by reporting week, Canada, 2013-2014


    Text equivalent for figure 5Percent positive influenza tests, compared to other respiratory viruses, Canada, by reporting week, 2011-2012

    Top of Page

    Influenza Strain Characterizations

    The National Microbiology Laboratory (NML) has not yet conducted antigenic characterization of influenza viruses in the 2013-14 season.
    Figure 6. Influenza strain characterizations, Canada, 2013-2014, N =0

    Note: The WHO recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus.
    Text equivalent for figure 6Influenza strain characterizations, Canada, 2011-2012

    Top of Page

    Antiviral Resistance

    The NML has not yet conducted antiviral resistance testing of influenza viruses in the 2013-14 season.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignCenter headers="cr2 cc2">0</TD><TD class=alignCenter headers="cr2 cc3">0</TD><TD class=alignCenter headers="cr2 cc5">0</TD><TD class=alignCenter headers="cr2 cc6">0</TD><TD class=alignCenter headers="cr2 cc8">0</TD><TD class=alignCenter headers="cr2 cc9">0</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignCenter headers="cr3 cc2">0</TD><TD class=alignCenter headers="cr3 cc3">0</TD><TD class=alignCenter headers="cr3 cc5">0</TD><TD class=alignCenter headers="cr3 cc6">0</TD><TD class=alignCenter headers="cr3 cc8">0</TD><TD class=alignCenter headers="cr3 cc9">0</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignCenter headers="cr4 cc2">0</TD><TD class=alignCenter headers="cr4 cc3">0</TD><TD class=alignCenter headers="cr4 cc5">0</TD><TD class=alignCenter headers="cr4 cc6">0</TD><TD class=alignCenter headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignCenter headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignCenter headers="cr5 cc2">0</TD><TD class=alignCenter headers="cr5 cc3">0</TD><TD class=alignCenter headers="cr5 cc5">0</TD><TD class=alignCenter headers="cr5 cc6">0</TD><TD class=alignCenter headers="cr5 cc8">0</TD><TD class=alignCenter headers="cr5 cc9">0</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate was similar over the past nine weeks; and was 10.5/1,000 in week 37 and increased slightly to 21.3/1,000 in week 38 (Figure 7). For three consecutive weeks since the beginning of the season, the highest consultation rate was observed in children 5-19 years of age: 25.7/1,000 visits in week 37 and 58.2/1,000 visits in week 38.
    Figure 7. Influenza-like illness (ILI) consultation rates, by report week, Canada, 2013-2014 compared to 1996/97 through to 2011/12 seasons (with pandemic data suppressed)

    Note: No data available for mean rate in previous years for weeks 19 to 39 (1996-1997 through 2002-2003 seasons). Delays in the reporting of data may cause data to change retrospectively.
    Text equivalent for figure 7Influenza-like illness (ILI) consultation rates, Canada, by report week, 2011-2012 compared to 1996/97 through to 2010/11 seasons (with pandemic data suppressed)

    Top of Page

    Severe Respiratory Illness Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    No laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations have been reported in any of the 12 hospitals participating in the Immunization Monitoring Program Active (IMPACT) network in weeks 37 or 38.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network concluded for the 2012-13 influenza season on April 30th, 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance, and active surveillance will start again on November 15th, 2013. No new hospitalizations, ICU admissions or deaths were reported in week 37 and no data was reported in week 38.
    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.
    Provincial/Territorial Influenza Hospitalizations and Deaths (Aggregate Surveillance System<SUP>*</SUP>)
    In weeks 37 and 38, no new laboratory-confirmed influenza-associated hospitalizations were reported from participating provinces and territories<SUP>*</SUP>. To date this season, two influenza-associated hospitalizations have been reported. Both cases were reported in adults 45-64 years of age. One ICU admission was reported among the two cases and no deaths were reported. The influenza-associated hospitalizations reported were influenza A (H1N1).
    * Note: The number of new influenza-associated hospitalizations and deaths reported by the Aggregate Surveillance System each week may be overestimated, as it may include retrospective updates to data from Ontario for previous weeks. These data may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.

    Top of Page

    International Influenza Update

    Northern Hemisphere

    Influenza activity in temperate regions of the northern hemisphere was at inter-seasonal levels in weeks 35 to 37. The US CDC reported a decrease in influenza detections in week 37 from week 35 and 36.
    World Health Organization influenza update
    Centers for Disease Control and Prevention seasonal influenza report
    EuroFlu weekly electronic bulletin
    Tropical Regions

    Asia & Africa: Influenza activity remained low in most countries in tropical Asia. Hong Kong, China Special Administrative Region, continued to observe a predominance of A(H3N2) after a switch from A(H1N1)pdm09 a few weeks earlier. Countries in Southeast Asia reported decreasing circulation of influenza A. Most countries in central Africa reported low or decreasing influenza activity, although C?te d?Ivoire, Ghana and Kenya reported continued influenza circulation.
    Carribean, Central America & tropical South America: Influenza activity in Caribbean and Central America continued to decrease and appears to have come to an end. In the majority of countries still seeing activity, co-circulation of influenza A(H3N2) and A(H1N1)pdm09 was reported, with the exception of Honduras, where influenza B was circulating. In tropical South America, acute respiratory virus activity continued to decrease and co-circulation of influenza A(H1N1)pdm09 and influenza B was reported in Bolivia, Ecuador and Peru.
    World Health Organization influenza update
    PAHO Influenza Situation Report
    Southern Hemisphere

    Influenza activity continued to decline in countries in South America as well as in South Africa. Activity in Oceania has been increasing in recent weeks and may be reaching its plateau.
    South America - Southern Cone: Acute respiratory virus activity was within the expected level for this time of year in all countries except Paraguay where ILI activity was elevated. RSV predominated in most countries with co-circulation of influenza B and A(H3N2) in Paraguay and Uruguay. In Argentina, laboratory detections peaked in week 27, and the number of ILI reports declined and was within the expected range in week 37. In Chile, the ILI activity rate in week 37 was similar to previous weeks; RSV and influenza detections declined from weeks 29-33, rose slightly in week 34, and declined again in week 35 and 36. In Paraguay, ILI activity decreased in week 37, but influenza virus detections increased from the previous week. In Uruguay, influenza activity increased in week 37. In South and Southeast Brazil, influenza activity continued to decrease, with co-circulation of influenza A(H1N1)pdm09 and influenza B reported.
    South Africa: Circulation of A(H1N1)pdm09 was reported from April to July 2013, with a peak in laboratory detections in week 23. Influenza circulation in weeks 31-34 has shifted to a predominance of A(H3N2) and influenza B, observed among both ILI and SARI cases.
    South Africa Influenza surveillance report
    Australia & New Zealand: Compared to recent years, the start of the 2013 influenza season has been delayed in Australia and New Zealand. In New Zealand, consultation rates for ILI remained below the baseline level, and below the level of the previous two seasons. Laboratory detections of influenza increased in week 37 from week 36, but declined slightly in week 38. Among the 1594 influenza viruses identified between weeks 1 and 38, 43.8% were influenza B. Among the 600 subtyped influenza A viruses, 75.5% were A(H3N2). Australia has not released an updated report.
    New Zealand Public Health Surveillance
    Australia Influenza Report
    World Health Organization influenza update
    PAHO Influenza Situation Report
    WHO FluNet
    Emerging Respiratory Pathogens

    Human Avian Influenza
    Influenza A(H7N9): No new cases of human infection with avian influenza A(H7N9) have been reported by the World Health Organization (WHO) since 11 August 2013.
    PHAC ? Avian influenza (H7N9)
    WHO ? Avian influenza A(H7N9)
    Human Swine Influenza
    Influenza A(H3N2)v: Two additional cases of human infection with variant influenza A(H3N2)v was reported from Arkansas, USA, in week 37. To date in 2013, a total of 20 A(H3N2)v cases have been reported, and one person has been hospitalized.
    Centers for Disease Control and Prevention Influenza A(H3N2) Variant Virus
    Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    Since 13 September 2013, WHO has reported 18 additional cases of MERS-CoV infection in Saudi Arabia. The cases range in age from three to 75 years. Of the 18 cases, data was provided for eight cases. All eight are contacts of confirmed cases. Five are males and four are health care workers. Two of the cases were symptomatic and had underlying medical conditions. The remainder were asymptomatic or had mild symptoms. Four deaths were reported, with three occurring in Saudi Arabia. The fourth death was a previously laboratory-confirmed patient in Qatar. As a result of a recent update to the WHO laboratory testing recommendations, two patients, reported in Italy in June 2013 as laboratory-confirmed with MERS-CoV, have been reclassified as probable cases. As of 26 September 2013, 130 laboratory-confirmed cases of human infection with MERS-CoV have been reported, including 58 deaths. Most patients are male (63%, 77/124) and range in age from 2 to 94 years (median 50 years, n=125).
    PHAC ? Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    WHO ? Coronavirus infections

    ...

    Leave a comment:


  • Pathfinder
    replied
    Re: Canada FluWatch Weekly Reports 2013-2014 Season Weeks 35 &amp; 36

    Public Health Agency of Canada
    FluWatch

    Note:
    Due to technical difficulties, the FluWatch report for weeks 37 & 38 will not be available until Monday September 30, 2013.

    Weekly data on flu in Canada, and systems that monitor flu: FluWatch and Respiratory Virus Detection Surveillance System.

    Leave a comment:


  • Canada FluWatch Weekly Reports 2013-2014 Season Weeks 33 and 34

    FluWatch report: August 25 to September 7, 2013 (Weeks 35 & 36)

    Posted 2013-09-13For readers interested in the <ABBR title="Portable Document Format">PDF</ABBR> version, the document is available for downloading or viewing:
    <A title="Flu Watch (Version PDF, 113 KB - 6 pages)" href="http://www.phac-aspc.gc.ca/fluwatch/13-14/w36_13/pdf/fw2013-36-eng.pdf">FluWatch report: August 25 to September 7, 2013 (Weeks 35 & 36) (<ABBR title="Portable Document Format">PDF</ABBR> Version - 113 <ABBR title=Kilobytes>KB</ABBR> - 8 pages)

    ?? Help with PDF documents



    Overall Summary
    • Influenza activity in Canada remained at inter-seasonal levels during this 2-week period.
    • The number of laboratory tests positive for all respiratory viruses was similar to previous weeks.
    • The ILI consultation rate was stable in recent weeks.
    NOTE: This is the first report for the 2013-2014 influenza season. Fortnightly reports will continue until October 11, 2013. Laboratory detections reported through the Respiratory Virus Detection Surveillance System and influenza activity level maps continue to be updated weekly on the FluWatch website.

    Influenza Activity (geographic spread) and Outbreaks

    The number of regions reporting influenza activity was at inter-seasonal levels in weeks 35 and 36. During this period, six regions reported sporadic activity (Figure 1). Localized activity has not been reported since week 26 of the 2012-13 season (Figure 2). No new influenza outbreaks were reported in weeks 35 or 36 (Figure 3).

    Figure 1. Map of overall Influenza activity level by province and territory,
    Canada, Week 36





    Note: Influenza activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates (see graphs and tables) and reported outbreaks. Please refer to detailed definitions on the last page. For areas where no data is reported, late reports from these provinces and territories will appear on the FluWatch website.
    Text equivalent for figure 1Map of overall Influenza activity level by province and territory, Canada
    Figure 2. Number of influenza surveillance regions<SUP title="sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in">?</SUP> reporting widespread or localized influenza activity, Canada, by report week, 2013-2014 (N<SUP>*</SUP>=58)


    ?sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.
    * Total number of influenza surveillance regions in Canada
    Text equivalent for figure 2Number of influenza surveillance regions reporting widespread or localized influenza activity, Canada, by report week, 2011-2012 (N=56)
    Figure 3. Overall Number of Influenza Outbreaks, Canada, by Report Week, 2013-2014


    Text equivalent for figure 3Overall Number of Influenza Outbreaks, Canada, by Report Week, 2011-2012

    Top of Page

    Influenza and Other Respiratory Virus Detections

    The overall percentage of positive influenza tests was low and stable, at 0.6% in week 35 and 0.3% in week 36. Among the ten influenza viruses detected in weeks 35 and 36, eight were influenza A (Table 1). Detailed information on age and type/subtype was complete for eight cases. Five of the eight cases were adults 45-64 years of age with A(H1N1)pdm09 (Table 2).
    The percentage of positive tests for rhinovirus increased during this 2-week period from 17.7% in week 34 to 23.1% in week 36; although the number of positive tests was similar to previous weeks. The percentages of positive tests for other respiratory viruses were low in week 36: parainfluenza (3.1%), human metapneumovirus (hMPV) (0.1%), respiratory syncytial virus (RSV) (0.8%), coronavirus (0%) and adenovirus (1.7%) (Figure 5)<SUP>*</SUP>.
    * For more details, see the weekly Respiratory Virus Detections in Canada Report.
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION class=alignCenter>Table 1: Weekly & Cumulative numbers of positive influenza specimens
    by Provincial Laboratories, Canada, 2013-2014

    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=ar1 rowSpan=3>Reporting provinces</TH><TH id=ac1 colSpan=6>Weekly
    (August 25 to September 7, 2013)

    </TH><TH id=ac9 colSpan=6>Cumulative
    (August 25, 2013 to September 7, 2013)

    </TH></TR><TR class=bg-colour-yellow><TH id=ac2 colSpan=5 headers=ac1>Influenza A</TH><TH id=ac8 headers=ac1>Influenza
    B

    </TH><TH id=ac10 colSpan=5 headers=ac9>Influenza A</TH><TH id=ac16 headers=ac9>Influenza
    B

    </TH></TR><TR class=bg-colour-yellow><TH id=ac3 headers=ac2>A Total</TH><TH id=ac4 headers=ac2>A(H1)</TH><TH id=ac5 headers=ac2>A(H3)</TH><TH id=ac6 headers=ac2>Pand H1N1</TH><TH id=ac7 class=noWrap headers=ac2>A
    ( <ABBR title=unsubtyped>Un S</ABBR>)Table 1 note*

    </TH><TH headers="ac1 ac8">Total</TH><TH id=ac11 headers=ac10>A Total</TH><TH id=ac12 headers=ac10>A(H1)</TH><TH id=ac13 headers=ac10>A(H3)</TH><TH id=ac14 headers=ac10>Pand H1N1</TH><TH id=ac15 class=noWrap headers=ac10>A
    (Un S) Table 1 note*

    </TH><TH headers=ac16>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=13>* Unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available. Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Note: Weekly data is based on week of positive lab detection. Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals. </TD></TR></TFOOT><TBODY><TR><TH id=ar2 class=bg-colour-yellow headers=ar1><ABBR title="British Columbia ">BC</ABBR></TH><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar2 ac1 ac8">1 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar2 ac9 ac16">1 </TD></TR><TR><TH id=ar3 class=bg-colour-yellow headers=ar1><ABBR title=Alberta>AB</ABBR></TH><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac3">4 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac6">4 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar3 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac11">4 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac14">4 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar3 ac9 ac16">0 </TD></TR><TR><TH id=ar4 class=bg-colour-yellow headers=ar1><ABBR title=Saskatchewan>SK</ABBR></TH><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac3">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar4 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac11">1 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac10 ac15">1 </TD><TD class=alignCenter headers="ar1 ar4 ac9 ac16">0 </TD></TR><TR><TH id=ar5 class=bg-colour-yellow headers=ar1><ABBR title=Manitoba>MB</ABBR></TH><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar5 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar5 ac9 ac16">0 </TD></TR><TR><TH id=ar6 class=bg-colour-yellow headers=ar1><ABBR title=Ontario>ON</ABBR></TH><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac3">3 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac5">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac6">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac2 ac7">1 </TD><TD class=alignCenter headers="ar1 ar6 ac1 ac8">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac11">3 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac13">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac14">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac10 ac15">1 </TD><TD class=alignCenter headers="ar1 ar6 ac9 ac16">1 </TD></TR><TR><TH id=ar7 class=bg-colour-yellow headers=ar1><ABBR title=Quebec>QC</ABBR>


    </TH><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar7 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar7 ac9 ac16">0 </TD></TR><TR><TH id=ar8 class=bg-colour-yellow headers=ar1><ABBR title="New Brunswick">NB</ABBR>


    </TH><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar8 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar8 ac9 ac16">0 </TD></TR><TR><TH id=ar9 class=bg-colour-yellow headers=ar1><ABBR title="Nova Scotia ">NS</ABBR>


    </TH><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar9 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar9 ac9 ac16">0 </TD></TR><TR><TH id=ar10 class=bg-colour-yellow headers=ar1><ABBR title="Prince Edward Island ">PE</ABBR>


    </TH><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar10 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar10 ac9 ac16">0 </TD></TR><TR><TH id=ar11 class=bg-colour-yellow headers=ar1><ABBR title="Newfoundland/Labrador ">NL</ABBR>


    </TH><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac3">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac5">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac6">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac2 ac7">0 </TD><TD class=alignCenter headers="ar1 ar11 ac1 ac8">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac11">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac13">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac14">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac10 ac15">0 </TD><TD class=alignCenter headers="ar1 ar11 ac9 ac16">0 </TD></TR><TR><TH id=ar12 class=bg-colour-yellow headers=ar1>Canada</TH><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac3">8 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac4">0 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac5">1 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac6">5 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac2 ac7">2 </TD><TD class=alignCenter headers="ar1 ar12 ac1 ac8">2 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac11">8 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac12">0 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac13">1 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac14">5 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac10 ac15">2 </TD><TD class=alignCenter headers="ar1 ar12 ac9 ac16">2 </TD></TR></TBODY></TABLE>
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 2. Weekly & Cumulative numbers of positive influenza specimens by age groups
    reported through case-based laboratory reporting, Canada, 2013-2014 Table 2 note*

    </CAPTION><THEAD><TR class=bg-colour-yellow><TH id=br1 rowSpan=3>Age groups</TH><TH id=bc1 colSpan=5>Weekly
    (August 25 to September 7, 2013)

    </TH><TH id=bc8 colSpan=5>Cumulative
    (August 25, 2013 to September 7, 2013)

    </TH></TR><TR class=bg-colour-yellow><TH id=bc2 colSpan=4 headers=bc1>Influenza A</TH><TH id=bc7 headers=bc1>B</TH><TH id=bc9 colSpan=4 headers=bc8>Influenza A</TH><TH id=bc14 headers=bc8>B</TH></TR><TR class=bg-colour-yellow><TH id=bc3 headers=bc2>A Total</TH><TH id=bc4 headers=bc2>Pandemic H1N1</TH><TH id=bc5 headers=bc2>A/H3N2</TH><TH id=bc6 headers=bc2>A unsubtyped</TH><TH headers="bc1 bc7">Total</TH><TH id=bc10 headers=bc9>A Total</TH><TH id=bc11 headers=bc9>Pandemic H1N1</TH><TH id=bc12 headers=bc9>A/H3N2</TH><TH id=bc13 headers=bc9>A unsubtyped</TH><TH headers=bc14>Total</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=11>* Please note that this table reflects the number of specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported. Delays in the reporting of data may cause data to change retrospectively.</TD></TR></TFOOT><TBODY><TR><TH id=br2 headers=br1><5</TH><TD class=alignCenter headers="br1 br2 bc1 bc2 bc3">2 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc5">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br2 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc10">2 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br2 bc8 bc9 bc13">1 </TD><TD class=alignCenter headers="br1 br2 bc8 bc14">0 </TD></TR><TR><TH id=br3 headers=br1>5-19</TH><TD class=alignCenter headers="br1 br3 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br3 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br3 bc8 bc14">0 </TD></TR><TR><TH id=br4 headers=br1>20-44</TH><TD class=alignCenter headers="br1 br4 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br4 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br4 bc8 bc14">0 </TD></TR><TR><TH id=br5 headers=br1>45-64</TH><TD class=alignCenter headers="br1 br5 bc1 bc2 bc3">5 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc4">5 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br5 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc10">5 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc11">5 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br5 bc8 bc14">0 </TD></TR><TR><TH id=br6 headers=br1>65+</TH><TD class=alignCenter headers="br1 br6 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br6 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br6 bc8 bc14">1 </TD></TR><TR><TH id=br7 headers=br1>Unknown</TH><TD class=alignCenter headers="br1 br7 bc1 bc2 bc3">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc4">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc5">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc2 bc6">0 </TD><TD class=alignCenter headers="br1 br7 bc1 bc7">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc10">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc11">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc12">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc9 bc13">0 </TD><TD class=alignCenter headers="br1 br7 bc8 bc14">0 </TD></TR><TR><TH id=br8 headers=br1>Total</TH><TD class=alignCenter headers="br1 br8 bc1 bc2 bc3">7 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc4">5 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc5">1 </TD><TD class=alignCenter headers="br1 br8 bc1 bc2 bc6">1 </TD><TD class=alignCenter headers="br1 br8 bc1 bc7">1 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc10">7 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc11">5 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc12">1 </TD><TD class=alignCenter headers="br1 br8 bc8 bc9 bc13">1 </TD><TD class=alignCenter headers="br1 br8 bc8 bc14">1 </TD></TR></TBODY></TABLE>


    Top of Page

    Figure 4. Influenza tests reported and percentage of tests positive,
    by report week, Canada, 2013-2014


    Text equivalent for figure 4Influenza tests reported and percentage of tests positive, Canada, by report week, 2011-2012
    Figure 5. Percent positive influenza tests, compared to other respiratory viruses,
    by reporting week, Canada, 2013-2014


    Text equivalent for figure 5Percent positive influenza tests, compared to other respiratory viruses, Canada, by reporting week, 2011-2012

    Top of Page


    Influenza Strain Characterizations

    The National Microbiology Laboratory (NML) has not yet conducted antigenic characterization of influenza viruses in the 2013-14 season.
    Figure 6. Influenza strain characterizations, Canada, 2013-2014, N =0

    Note: The WHO recommended components for the 2013-2014 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009 (H1N1)pdm09-like virus, an A(H3N2) virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011b, and a B/Massachusetts/2/2012-like virus.
    Text equivalent for figure 6Influenza strain characterizations, Canada, 2011-2012

    Top of Page


    Antiviral Resistance

    The NML has not yet conducted antiviral resistance testing of influenza viruses in the 2013-14 season (Table 3).
    <TABLE class=widthFull border=1 cellSpacing=0 cellPadding=2><CAPTION>Table 3. Antiviral resistance by influenza virus type and subtype, Canada, 2013-2014</CAPTION><THEAD><TR class=bg-colour-yellow><TH id=cr1 rowSpan=2>Virus type and subtype</TH><TH id=cc1 colSpan=2>Oseltamivir</TH><TH id=cc4 colSpan=2>Zanamivir</TH><TH id=cc7 colSpan=2>Amantadine</TH></TR><TR class=bg-colour-yellow><TH id=cc2 headers=cc1># tested</TH><TH id=cc3 headers=cc1># resistant (%)</TH><TH id=cc5 headers=cc4># tested</TH><TH id=cc6 headers=cc4># resistant (%)</TH><TH id=cc8 headers=cc7># tested</TH><TH id=cc9 headers=cc7># resistant (%)</TH></TR></THEAD><TFOOT><TR><TD class=fontSize85 colSpan=7><SUP>*</SUP> NA - not applicable</TD></TR></TFOOT><TBODY><TR><TH id=cr2 class="alignLeft bg-colour-blue" headers=cr1>A (H3N2)</TH><TD class=alignRight headers="cr2 cc2">0</TD><TD class=alignRight headers="cr2 cc3">0</TD><TD class=alignRight headers="cr2 cc5">0</TD><TD class=alignRight headers="cr2 cc6">0</TD><TD class=alignRight headers="cr2 cc8">0</TD><TD class=alignRight headers="cr2 cc9">0</TD></TR><TR><TH id=cr3 class="alignLeft bg-colour-blue" headers=cr1>A (H1N1)</TH><TD class=alignRight headers="cr3 cc2">0</TD><TD class=alignRight headers="cr3 cc3">0</TD><TD class=alignRight headers="cr3 cc5">0</TD><TD class=alignRight headers="cr3 cc6">0</TD><TD class=alignRight headers="cr3 cc8">0</TD><TD class=alignRight headers="cr3 cc9">0</TD></TR><TR><TH id=cr4 class="alignLeft bg-colour-blue" headers=cr1>B</TH><TD class=alignRight headers="cr4 cc2">0</TD><TD class=alignRight headers="cr4 cc3">0</TD><TD class=alignRight headers="cr4 cc5">0</TD><TD class=alignRight headers="cr4 cc6">0</TD><TD class=alignRight headers="cr4 cc8">NA <SUP>*</SUP></TD><TD class=alignRight headers="cr4 cc9">NA <SUP>*</SUP></TD></TR><TR><TH id=cr5 class="alignLeft bg-colour-blue" headers=cr1>TOTAL</TH><TD class=alignRight headers="cr5 cc2">0</TD><TD class=alignRight headers="cr5 cc3">0</TD><TD class=alignRight headers="cr5 cc5">0</TD><TD class=alignRight headers="cr5 cc6">0</TD><TD class=alignRight headers="cr5 cc8">0</TD><TD class=alignRight headers="cr5 cc9">0</TD></TR></TBODY></TABLE>
    Influenza-like Illness (ILI) Consultation Rate

    The national influenza-like-illness (ILI) consultation rate was similar over the past seven weeks; and was 11.1/1,000 in week 35 and 13.9/1,000 in week 36 (Figure 7). The highest consultation rate was observed in adults ≥65 years of age (23.4/1,000 visits) in week 35 and in children 5-19 years of age in week 36 (38.7/1,000 visits).
    Figure 7. Influenza-like illness (ILI) consultation rates, by report week, Canada, 2013-2014 compared to 1996/97 through to 2011/12 seasons (with pandemic data suppressed)

    Note: No data available for mean rate in previous years for weeks 19 to 39 (1996-1997 through 2002-2003 seasons). Delays in the reporting of data may cause data to change retrospectively.
    Text equivalent for figure 7Influenza-like illness (ILI) consultation rates, Canada, by report week, 2011-2012 compared to 1996/97 through to 2010/11 seasons (with pandemic data suppressed)

    Top of Page


    Severe Respiratory Illness Surveillance

    Paediatric Influenza Hospitalizations and Deaths (IMPACT)
    No laboratory-confirmed influenza-associated paediatric (≤16 years of age) hospitalizations have been reported in any of the 12 hospitals participating in the Immunization Monitoring Program Active (IMPACT) network in weeks 35 or 36.
    Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Adult Influenza Hospitalizations and Deaths (PCIRN)
    Active surveillance of laboratory-confirmed influenza-associated adult (≥16 years of age) hospitalizations reported by the PHAC/CIHR Influenza Research Network (PCIRN) Serious Outcomes Surveillance (SOS) network concluded for the 2012-13 influenza season on April 30th, 2013. The PCIRN-SOS network continues to report limited data on laboratory-confirmed cases of influenza identified through passive surveillance at 15 out of 17 hospital sites, and active surveillance will start again on November 15th, 2013. No new hospitalizations, ICU admissions or deaths were reported in weeks 35 and 36.

    Note: The number of hospitalizations reported through PCIRN represents a subset of all influenza-associated adult hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

    Provincial/Territorial Influenza Hospitalizations and Deaths (Aggregate Surveillance System<SUP>*</SUP>)

    In the first two weeks of the 2013-14 season, two laboratory-confirmed influenza-associated hospitalizations were reported from five of the nine participating provinces and territories*. Both cases were adults 45-64 years of age with A(H1N1)pdm09, of which one was admitted to the ICU.
    * Note: The number of new influenza-associated hospitalizations and deaths reported by the Aggregate Surveillance System each week may be overestimated, as it may include retrospective updates to data from Ontario for previous weeks. These data may also include cases reported by the IMPACT and PCIRN networks. Influenza-associated hospitalizations are not reported to PHAC by the following Provinces and Territory: BC, NU, QC, NS, and NB. Only hospitalizations that require intensive medical care are reported by Saskatchewan. ICU admissions are not reported in Ontario.

    Top of Page


    International Influenza Update

    Northern Hemisphere

    Influenza activity in temperate regions of the northern hemisphere was at inter-seasonal levels in weeks 34 to 35. However, the US CDC reported an increase in influenza A detections in weeks 35 and 36.
    World Health Organization influenza update
    Centers for Disease Control and Prevention seasonal influenza report
    EuroFlu weekly electronic bulletin

    Tropical Regions

    Asia & Africa: Influenza activity remained low in most countries in tropical Asia. Hong Kong, China Special Administrative Region, reported a switch from A(H1N1)pdm09 circulation to predominantly A(H3N2). Countries in Southeast Asia reported decreasing circulation of influenza A. Most countries in central Africa reported low or decreasing influenza activity, although C?te d'Ivoire and Ghana reported continued influenza circulation.
    Carribean, Central America & tropical South America: Influenza activity in Caribbean and Central America continued to decrease, with influenza A(H3N2) and A(H1N1)pdm09 co-circulating in varying proportions in different countries. In tropical South America, influenza activity decreased in Bolivia, Brazil, Colombia and Venezuela. Peru reported a sharp increase in A(H1N1)pdm09 circulation in weeks 29-32, but detections have been decreasing in weeks 33 and 34. In Bolivia, the proportion of SARI hospitalizations showed an increasing trend, primarily associated with A(H1N1)pdm09.
    World Health Organization influenza update
    PAHO Influenza Situation Report

    Southern Hemisphere

    Influenza activity continued to decline in countries in South America as well as in South Africa. Activity in Oceania has been increasing in recent weeks and may be reaching its plateau.

    South America - Southern Cone: Influenza and RSV circulation declined in several countries in temperate South America, although RSV continued to be the predominant respiratory virus in the region. Influenza detections peaked at the end of June, with a predominance of A(H1N1)pdm09 in all countries except Paraguay, where A(H3N2) was predominant. In Argentina, laboratory detections seem to have peaked in week 27, and the number of ILI reports declined and was within the expected range in week 34. In Chile, the ILI activity rate in week 34 was similar to previous weeks; RSV and influenza detections declined from weeks 29-33 but rose slightly in week 34. In Paraguay, ILI activity increased in week 34 although influenza A(H3N2) and RSV detections have been declining in weeks 28-34. In Brazil, influenza detections have been declining since a peak in week 24, with A(H1N1)pdm09 and influenza B co-circulating.

    South Africa: Circulation of A(H1N1)pdm09 was reported from April to July 2013, with a peak in laboratory detections in week 23. Influenza circulation in weeks 31-34 has shifted to a predominance of A(H3N2) and influenza B, observed among both ILI and SARI cases.
    South Africa Influenza surveillance report

    Australia & New Zealand: Compared to recent years, the start of the 2013 influenza season has been delayed in Australia and New Zealand. In New Zealand, consultation rates for ILI remained below the baseline level, and below the level of the previous two seasons. Laboratory detections of influenza increased in week 35 but declined in week 36. Among the 1183 influenza viruses identified between weeks 1 and 36, 47.2% were influenza B. Among the 405 subtyped influenza A viruses, 75.6% were A(H3N2). In Australia, the increase in influenza activity has slowed and activity remains lower than the previous 2 seasons. The ILI consultation rate increased in recent weeks, but declined in week 35; 25% of sentinel ILI specimens were positive for influenza between August 26 and September 1. The number of laboratory-confirmed influenza notifications continued to increase since early June. Among the 14,068 influenza viruses identified between 1 January and 30 August 2013, 65% were influenza A. Although the majority of influenza A have not been subtyped, to date approximately 15% have been A(H1N1)pdm09 in 2013 compared to <1% during the 2012 season. Most influenza B viruses characterized were from the Yamagata lineage.
    New Zealand Public Health Surveillance
    Australia Influenza Report
    World Health Organization influenza update
    PAHO Influenza Situation Report
    WHO FluNet

    Emerging Respiratory Pathogens

    Human Avian Influenza
    Influenza A(H7N9): No new cases of human infection with avian influenza A(H7N9) have been reported by the World Health Organization (WHO) since 11 August 2013.
    PHAC ? Avian influenza (H7N9)
    WHO ? Avian influenza A(H7N9)

    Human Swine Influenza

    Influenza A(H3N2)v: One new case of human infection with variant influenza A(H3N2)v was reported from Michigan, USA, in week 35. No cases were reported in week 36. To date in 2013, a total of 18 A(H3N2)v cases have been reported, and one person has been hospitalized.
    Centers for Disease Control and Prevention Influenza A(H3N2) Variant Virus

    Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    Since 30 August 2013, WHO has reported ten additional cases of MERS-CoV infection: eight cases, including three deaths, in Saudi Arabia; one case in Qatar who subsequently died; and one case in Tunisia (reported on 22 May 2013 as a deceased probable case, now confirmed). Four of the cases in Saudi Arabia are family contacts of at least one confirmed case. Two are asymptomatic paediatric cases. The remaining two are adults with underlying medical conditions, and one has died. Two healthcare workers with severe pneumonia were reported from the same health care facility. One had no known exposure to animals, or to a confirmed MERS-CoV case, and has died. The second health care worker was reported to be in critical condition. As of 12 September, 2013, 114 laboratory-confirmed cases of human infection with MERS-CoV have been reported, including 54 deaths. Most patients are male (61%; 67 of 110 cases) and range in age from 14 months to 94 years (median 50 years, n=107).
    PHAC ? Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    WHO ? Coronavirus infections

    .../
Working...
X